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ABSTRACT 
  Tissue engineering emerges nowadays to seek new solutions to damaged tissues 
and/or organs by replacing or repairing them with engineered constructs or scaffolds. 
In nerve tissue engineering, scaffolds for the repair of peripheral nerve injuries should 
act to support and promote axon growth following implantation. It is believed that 
substantial progress can be made by creating scaffolds from biomaterials, with 
growth-promoting molecules and spatially-controlled microstructure. To this end, this 
research aims to develop three dimensional (3D) scaffolds for peripheral nerve tissue 
regeneration by focusing on studies on the axon guidance, development and 
characterization of a novel 3D scaffold, and visualization of scaffolds by means of 
synchrotron-based diffraction enhanced imaging (DEI). 
  Axon guidance is one of crucial considerations in developing of nerve scaffolds for 
nerve regeneration. In order to study the axon guidance mechanism, a two 
dimensional (2D) grid micropatterns were created by dispensing chitosan or 
laminin-blended chitosan substrate strands oriented in orthogonal directions; and then 
used in the in vitro dorsal root ganglion (DRG) neuron culture experiments. The 
results show the effect of the micropatterns on neurite directional growth can 
preferentially grow upon and follow the laminin-blended chitosan pathways. 
  A novel 3D scaffold was developed for potential applications to peripheral nerve 
tissue engineering applications. The scaffolds were fabricated from poly L-lactide 
(PLLA) mixed with chitosan microspheres (CMs) by using a rapid freeze prototyping 
(RFP) technique, allowing for controllable scaffold microstructure and bioactivities 
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protein release. The scaffold characterization shows that (1) the mechanical properties 
of the scaffolds depend on the ratio of CMs to PLLA as well as the cryogenic 
temperature and (2) the protein release can be controlled by adjusting the crosslink 
degree of the CMs and prolonged after the CMs were embedded into the PLLA 
scaffolds. Also, the degradation properties of the scaffolds were investigated with the 
results showing that the addition of CMs to PLLA can decrease the degradation rate 
as compared to pure PLLA scaffolds. This allows for another means to control the 
degradation rate. 
  Visualization of polymer scaffolds in soft tissues is challenging, yet essential, to the 
success of tissue engineering applications. The x-ray diffraction enhanced imaging 
(DEI) method was explored for the visualization of the PLLA/CMs scaffolds 
embedded in soft tissues. Among various methods examined, including conventional 
radiography and in-line phase contrast imaging techniques, the DEI was the only 
technique able to visualize the scaffolds embedded in unstained muscle tissue as well 
as the microstructure of muscle tissue. Also, it has been shown that the DEI has the 
capacity to image the scaffolds in thicker tissue, and reduce the radiation doses to 
tissues as compared to conventional radiography. 
  The methods and results developed/obtained in this study represent a substantial 
progress in the development and characterization of 3D scaffolds. This progress forms 
a basis for the future tests on the scaffolds as applied for peripheral nerve injuries. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Peripheral nerve tissue engineering (NTE) 
  Peripheral nerve system (PNS) injuries can lead to the lifetime loss of neurological 
function and approximately 200,000 nerve repair procedures are performed annually 
in the United States alone [1]. After peripheral nerve injury (PNI), the distal portion of 
the nerve undergoes degeneration, in which severed axons die and Schwann cells shed 
their myelin [2], leading the loss of neurological function. On the other hand, the 
proximal segment may be able to regenerate and reestablish nerve function, 
depending upon the length of injury gap. If the gap is long, the PNI must be surgically 
treated. Currently, the "gold standard" of clinical treatments for the long-gap PNI uses 
a donor nerve from a different location to bridge the severed nerve. However, the 
method still is limited as it requires two incisions for donor harvest and repair thus 
causing donor site morbidity and the functional recovery from this method is always 
not complete [3]. Peripheral NTE aimed at developing nerve conduit scaffolds are a 
promising approach to promote functional recovery of the injured nerves [4, 5].  
  Figure 1.1 schematically illustrates the concepts of PNI and its repair by means of a 
conduit scaffold. In the literature, non-nerve autologous tissues such as blood vessels 
[6, 7] and skeletal muscles [8] have been used as conduits to promote axon 
regeneration and functional recovery. As harvested from the patients themselves, the 
autologous tissues are immunologically compatible, thus possessing optimal 
donor-host integration characteristics. The use of autologous tissues also requires a 
second surgery, in addition to the shortcoming of incompatibility in terms of size or 
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dimension. As alternatives to autologous tissues, a number of non-autologous 
biological tissues have been reported for peripheral nerve repair. Acellular 
non-autologous nerve grafts obtained from animals were used as a conduits [9, 10]. 
Although extracellular matrix (ECM) based nerve conduits, which are plentiful, are 
able to promote cellular attachment, migration and axon extension, they present risks 
with immunogenic mismatching and possible transmission of disease [11]. 
Non-biodegradable nerve conduits have also been used to bridge peripheral nerve 
lesions. Non-biodegradable nerve conduits are typically made from 
non-biodegradable materials such as silicone [12] and polytetrafluoroethylene (PTFE) 
[13]. Numerous trials have shown that, owing to unmatched mechanical properties 
between non-biodegradable materials and nerve tissues, the implants may lead to 
chronic nerve compression, decreased neovascularization, and increased scarring [14]. 
 
Figure 1.1 (a) Schematic of peripheral nerve injury and (b) regeneration by using a 
nerve conduit scaffold.1 
 
  Currently, biodegradable nerve conduit scaffolds has been emerging and showing 
promise in peripheral NTE. Due to their biodegradability, the scaffolds degenerate in 
vivo and are eventually bioabsorbed by the surrounding tissues at the implanted site. 
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In contrast, non-degradable materials tend to accumulate toxic levels of waste 
products and even constrict the nerve, thus impairing nerve function once regenerative 
axons have traversed the gap [15]. While previous studies show the potential of the 
biodegradable scaffold, numerous issues must be addressed before they can be applied 
clinically. The present study is aimed at addressing some of the issues, particularly 
focusing on the axon guidance and the development and characterization of 
biodegradable scaffolds in NTE. 
 
1.2 Brief introduction to the development of biodegradable scaffolds for NTE 
1.2.1 Requirements imposed on the biodegradable NTE scaffolds 
  Generally speaking, scaffolds for peripheral nerve regeneration should mimic the 
structure and properties of native nerves so as to support and direct the process of 
neo-tissue formation. Ideally, a nerve conduit scaffold should have the following 
properties and characteristics [16-18], as illustrated in Figure 1.2. 
(1) Biocompatibility: the scaffold materials should have a high affinity for cells to 
attach, differentiate, and proliferate, but not induce any adverse response. 
(2) Microstructure: scaffolds should possess interconnected porous microstructure 
with appropriate pore sizes to favor tissue integration and vascularization. The porous 
microstructure also contributes significantly to the diffusion of nutrients and 
metabolic wastes.  
(3) External shape: scaffolds should have a nerve conduit shape allowing the 
regenerative nerves across the scaffolds to reach the distal end of the severed nerve. 
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(4) Mechanical properties: scaffolds should possess adequate mechanical properties to 
match the intended site of implantation. 
(5) Biodegradablility: the degradation rate of the scaffolds should be controllable and 
appropriate with the regeneration process of new nerve tissues.  
(6) Axon guidance cues: a nerve conduit scaffold should carry bioactive molecules, 
such as growth factors, and provide directional cues for axon guidance. 
 
Figure 1.2 Schematic illustration of an ideal nerve conduit scaffold for peripheral 
nerve regeneration (modified from [19]).2 
 
1.2.2 Biodegradable biomaterials for NTE scaffolds 
  A wide range of biodegradable biomaterials has been used in the development of 
nerve tissue scaffolds. Generally, these biomaterials can be classified into two 
categories: synthetic and naturally derived materials. 
(1) Synthetic materials: 
  Synthetic materials have many advantages, including (a) they have known 
compositions and can be designed to minimize the immune response; and (b) a range 
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of mechanical properties and degradation rates of the synthetic polymers can be 
tailored to match the requirements of a specific tissue engineering application. Figure 
1.3 shows the chemical structures of the common synthetic polymers used in nerve 
tissue which are briefly reviewed as follows. 
  Poly (lactic acid) or poly lactide (PLA) has been proved to be the most attractive 
and useful category of biodegradable polyesters, which can be prepared by both direct 
condensation of lactic acid or the ring-opening polymerization of the cyclic lactide 
dimer [20]. PLA can be semi-crystalline or totally amorphous, depending on the 
stereopurity of the polymer backbone. PLA undergoes hydrolytic degradation with the 
random scission of the ester backbone. It degrades into lactic acid, which is a normal 
human metabolic by-product and can be resorbed by human bodies [21]. As such, 
PLA has been approved by the United States Food and Drug Administration and 
widely used in the development of commercial bioabsorbable biomedical devices, 
such as bone screws [22], stents [23], sutures [24], etc. Based on the chiral nature of 
lactic acid, PLA has been found in two stereoisomeric forms: L-lactide and D-lactide. 
Poly (L-lactide) (PLLA) is a product resulting from polymerization of L-lactide which 
is the natural and most common form of the acid. PLLA not only possesses good 
mechanical strength and biodegradation properties, but also can be easily processed 
by various conventional processing techniques. Therefore, PLLA has been popularly 
used to build tissue scaffolds. With regard to PNI repair, PLLA nerve conduit 
scaffolds have been successfully applied and reported in the literature [25, 26]. Also 
studies of PLLA have also been conducted to investigate into neurite alignment [27], 
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cytocompatibiliy [28, 29], and material modification promoting neurite outgrowth [30, 
31]. 
  Besides PLA, other synthetic polymers applied in NTE include Poly (glycolic acid) 
(PGA), poly (lactide-co-glycolide) (PLGA), polycaprolactone (PCL), and 
poly-3-hydroxybutyrate (PHB) (Figure 1.3). PGA is the simplest linear, aliphatic 
polyester [32]. It is a high crystalline polymer and therefore exhibits excellent 
mechanical properties. Due to its slow degradation rate, the copolymerization of 
glycolic acid (GA) and lactic acid (LA) - PLGA has been investigated for 
improvement. In NTE, PLGA has been applied in the fabrication of scaffolds [33, 34] 
or microspheres for drug delivery [35]. PCL is a semi-crystalline polyester and has 
low tensile strength, but an extremely high elongation at breakage [36]. In NTE, PCL 
has been studied to build nerve conduit scaffolds either alone [37] or in combination 
with other materials, such as chitosan [38], gelatin [39], and collagen [40]. PHB has 
been studied as a nerve conduit scaffold material in NTE applications for the last 
decade [41-43]. PHB can be degraded in either a enzymatic or non-enzymatic 
environment. PHB is considered to be moderately resistant to degradation in vitro and 
in vivo compared to PLA and PLGA [44]. 
 
Figure 1.3 Chemical structures of common synthetic biodegradable polymers used in 
peripheral nerve tissue engineering.3 
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(2) Natural materials:  
  Natural materials possess many properties that make them attractive for NTE 
applications, which includes excellent biocompatibility and similar properties to the 
soft tissues being replaced. However, natural materials must be purified to reduce the 
risk of foreign body response upon implantation. Homogeneity of products from 
different source locations can be another issue with natural materials. Several natural 
polymers that have been typically studied in NTE are reviewed as follows. 
  Chitosan is a deacetylated derivative of chitin found in arthropod exoskeletons. It is 
the second most abundant biopolymer in nature. Chitosan is a linear polysaccharide 
consisting of β(1→4) linked D-glucosamine residues with a variable number of 
randomly located N-acetyl-glucosamine groups [45]. The degree of deacetylation (DD) 
of chitosan is an important characteristic which greatly affects its biological properties 
[46] and physicochemical properties (e.g. crystallinity, swelling ratio, and mechanical 
property) [47, 48]. The degradation behaviors of chitosan are also dependent on the 
DD [49, 50] and chitosan can quickly degrade in the presence of lysozyme [51]. 
Chitosan is a attractive biomaterial in biomedical applications due to its 
biocompatibility, biodegradability, low immunogenicity and low cost [52, 53]. 
Chitosan scaffolds have been explored in numerous tissue engineering applications 
[54] especially in nerve regeneration [55, 56]. Furthermore, one of chitosan's 
promising features is its cationic nature, which allows for forming ionic complexes 
with various anionic substances in an acidic environment and dissociating a portion of 
the complexes in a physiological solution (pH 7.4). This characteristic is beneficial to 
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carry and accumulate bioactive molecules for their sustained release from the chitosan 
matrix [57]. Therefore, chitosan has also been widely used as a bioactive molecule 
carrier for neurotrophins release during nerve tissue regeneration [58, 59]. 
  Other natural materials applied in NTE include collagens, alginate, and fibroin. 
Collagens are the most abundant protein present in the human body being the major 
component of skin and other musculoskeletal tissues. It is among the most popular 
biomaterials in various tissue engineering applications [60]. Collagen conduits have 
proven to successfully support axon regeneration in a degree similar to that supported 
by autografts [61-63]. Collagens have also been used, in a form of hydrogel, with 
other biomaterials to promote axon regeneration [64, 65]. Alginate is a linear 
polysaccharide obtained from seaweed or algae [66]. Alginate gels have good 
cell-affinity and can enhance cell survival and growth. As such the polymer can be 
used to develop cell-binding hydrogels for use as scaffolds for tissue engineering [67]. 
In NTE, scaffolds made from alginate are capable of maintaining the viability and 
function of a variety of neural cell types [68]. Alginate-based scaffolds encapsulated 
with nerve support cells have been reported for peripheral nerve regeneration [69].  
Fibroin from the silkworm, which is another class of natural fibers [70], has been 
demonstrated to have good biocompatibility with peripheral nerve cells in vitro [71, 
72].  
 
1.2.3 Scaffold fabrication techniques 
  A number of conventional techniques have been widely used to process synthetic 
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and natural biodegradable biomaterials into NTE scaffolds, including solvent-casting 
and particulate-leaching [73], gas foaming [74], phase separation [75], melt molding 
[76], freeze drying [77], and electrospinning [78]. The solvent-casting and 
particulate-leaching techniques can be used to fabricate porous scaffolds with a 
porosity up to 93% and an average pore diameter up to 500 μm [79]. However, these 
techniques are limited to produce thin membranes up to 3 mm in thickness [80]. The 
gas foaming process creates a porous structure by using gas-foaming agents, such as 
CO2 and nitrogen [81], water [82], or fluoroform [83]. The process is organic solvent 
free; and its main drawback is possibly yielding a largely unconnected porous 
structure and a non-porous external surface [84]. Using phase separation [85] or 
freeze dry techniques [86, 87], the micro- and macro-structure of the scaffolds can be 
controlled by varying processing parameters, such as polymer concentration, 
quenching temperature, and rate. As these processes are carried out under 
relatively-low temperatures, they allow for the incorporation of bioactive molecules to 
scaffolds during their fabrication. Melt molding is a non-solvent fabrication process, 
but needs a high processing temperature for operation and as such, it would not allow 
for incorporation of with bioactive molecules [88]. The electrospinning technique has 
been employed nowadays to fabricate porous scaffolds with nanofibrous 
microstructure, thus possibly mimicking the structure and biological functions of the 
natural extracellular matrix [89]. Concerns about this technique include the 
uncontrollable collection of fibers during the process, and the relatively-small space 
formed among the fibers which might limit cell penetration in the scaffold. 
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  As an alternative to conventional scaffold fabrication methods, a group of rapid 
prototyping techniques (RP) has recently been developed in tissue engineering [90, 
91]. RP techniques utilize the layer-manufacturing strategy to fabricate 
three-dimensional (3D) scaffolds with the help of computer-assisted-design (CAD) 
and computer-assisted-manufacturing (CAM) techniques. RP allows better control of 
scaffold internal structure and external shape compared to conventional fabrication 
techniques [92, 93]. RP-based scaffold fabrication can be classified three types: 
liquid-based, solid-based, and powder-based, according to the properties of the 
scaffold biomaterials used. The main RP processes applied in tissue scaffold 
fabrication include stereolithography [94], selective laser sintering [95], fused 
deposition modeling [96], and 3D printing [97]. Recently, RP techniques also have 
shown their capacities to incorporate living cells [98, 99] and growth factors [100] 
into the scaffolds during the fabrication process thus building bio-mimetic tissue 
scaffolds. 
 
1.2.4 Scaffolds as carriers for drug delivery 
  In NTE, some proteins play an important role as bioactive factors in enhancing 
nerve regeneration across peripheral nerve gaps which include neurotrophins and 
neurostimulatory ECM proteins [18]. Research has shown that these factors have 
influence on neural development, survival, outgrowth, and branching [101]. The most 
common growth factors used to promote neural tissue regeneration are neurotrophins 
such as nerve growth factor (NGF), brain derived neurotrophic factor (BNDF), 
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neurotrophin-3 (NT-3), and neurotrophin-4/5(NT-4/5). Other growth factors that have 
been studied for their ability to promote nerve regeneration include ciliary 
neurotrophic factor (CNTF), glial cell line-derived growth factor (GDNF), 
transforming growth factor β (TGF-β), and acidic and basic fibroblast growth factor 
(aFGF, bFGF) [101, 102]. Furthermore, neurostimulatory ECM proteins, such as 
laminin and fibronectin, can provide stimulatory cues for neurite extension [103]. 
  The local delivery of these proteins is desirable due to the fact that the proteins 
often have short half-lives and multiple biological effects that present the risks of 
potential systemic toxicity [104]. As a local delivery method, scaffolds carried with 
bioactive molecules have shown promise to promote and guide cell-induced tissue 
regeneration through a control of the local microenvironment in which the molecules 
can be exposed at the desired site and be released with sufficient local dose in the 
required time frame [102]. The proteins can be directly interspersed within the 
scaffolds or encapsulated in micro- or nano- particles interspersed in the scaffold 
structure. The proteins released from the micro- or nano- particles in scaffolds could 
overcome the disadvantages of direct release from scaffolds, including poor release 
rate control and the loss of growth factor bioactivity [105]. To mimic the natural 
biological process, nerve conduit scaffolds should not be limited to a single 
neurotrophin or ECM protein, but rather should release multiple bioactive molecules 
at an optimized ratio, each at a physiological dose [106]. Also, scaffolds with a 
specific spatial gradient of proteins may built with directional cues to enhance nerve 
regeneration [107]. 
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1.3 Research issues and objectives 
  The aim of this research is to develop 3D scaffolds for peripheral nerve tissue 
regeneration by focusing on the axon guidance, development and characterization of a 
novel 3D scaffold, and visualization of scaffolds by means of synchrotron-based 
diffraction enhanced imaging (DEI). 
 
1.3.1 Axon guidance 
  In NTE, axon guidance is crucial to successful nerve regeneration [101, 108]. Axon 
growth and guidance may be mediated by many permissive factors, including scaffold 
biomaterials [71, 109, 110] and microstructure [111], growth-promoting and signaling 
molecules [112-114], as well as chemical gradients [115]. The challenge of axon 
guidance in scaffolds is that the scaffolds should deliver appropriate cues in a 
controlled and localized manner.  
  The first objective of the present study is to study the influence of scaffold 
materials on the axon guidance, specifically, to investigate the addition of laminin to 
chitosan scaffolds for promoting axon guidance in cultured adult dorsal root ganglion 
neurons. For this, scaffolds are created from chitosan with varying amounts of laminin 
added, and with controllable structure by means of a rapid prototyping technique - 
dispensing-based rapid prototyping (DBRP). The scaffold's influence on the growth 
and orientation of neurites is then studied in vitro. 
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1.3.2 Development and characterization of three-dimensional scaffolds 
  Scaffolds have been shown to be critical in tissue engineering. As mentioned in 
section 1.2.1, one of the challenges in NTE is to develop nerve conduit scaffolds with 
adjustable and controllable microstructure, mechanical properties, drug delivery, and 
degradation properties, in order to meet the requirements for a given PNI application. 
Scaffolds made from a single material hardly meet the comprehensive requirements 
for nerve tissue regeneration. Composite materials take advantage of the unique 
properties of each compound in the composite. RP techniques have shown promise for 
fabricating scaffolds with a controllable structure. A limitation of RP, however, is the 
high operating temperature of the system which can cause degradation of the 
materials and also limit the incorporation of biomolecules into the scaffolds [92, 116]. 
The combination of RP with freeze dry techniques (the rapid freeze prototyping 
technique - RFP) can avoid this drawback of RP and has potential to fabricate 
scaffolds with enhanced properties. 
  The second objective of the present study is to develop and characterize a novel 3D 
composite scaffold made from PLLA and chitosan microspheres (CMs). The scaffolds 
are fabricated by using the RFP, which combines RP with the freeze dry technique; 
and the CMs are fabricated by means of the emulsification method, particularly for 
the purpose of bioactive molecule delivery. The scaffolds are then characterized in 
terms of microstructure, mechanical properties, degradation behavior, and protein 
release behaviours. 
 
14 
 
1.3.3 Visualization of scaffolds by means of synchrotron-based diffraction 
enhanced imaging 
    In NTE, different visualization techniques are available to study tissues, tissue 
structures, and biomaterials/scaffolds. Scanning electron microscopy (SEM) is a 
surface measurement method which can be used to observe the surface features of 
scaffolds and cells [117]. Confocal laser scanning microscopy (CLSM) can visualize 
objects in 3D and requires fluorescent labeling [118], whereas the resolution in depth 
of the images is restricted to the micrometer scale. X-ray micro-computed 
tomography (μCT) is a nondestructive and noninvasive quantification method and can 
be used to perform 3D morphometric analysis of scaffolds and regenerative tissues. 
μCT techniques are becoming increasingly important to tissue engineering research in 
recent years [119]. However, there have been few applications of μCT in NTE. The 
main obstacle is the low x-ray attenuation contrast of low density polymer scaffolds 
and nerve tissues. Coupling synchrotron radiation based (SR) x-ray sources to μCT 
imaging techniques offers advantages such as better image quality, high photon flux, 
the possibility for monochromatization with a brilliance several orders of magnitude 
higher than those of a standard x-ray source, high spatial resolution (< 1 μm), a better 
signal-to-noise ratio, and the potential to lower the radiation dose by tissue samples 
[120]. One of the SR x-ray phase contrast imaging techniques, DEI, has shown its 
potential in the visualization of soft tissues [121]. However, its application to tissue 
engineering has not been reported in the literature. 
  The third objective of the present study is to explore the feasibility of visualizing 
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polymer scaffolds in vivo by using the DEI technique. For this, 3D PLLA/chitosan 
scaffolds embedded in rat muscle tissue are imaged by using DEI. The image contrast, 
radiation dose, and the limitation of sample thickness are also investigated.  
 
1.4 Organization of the Dissertation 
  This dissertation is comprised of seven chapters. Besides this chapter, it includes 
five 
manuscripts, followed by the conclusions drawn from this research. 
  Chapter 2 presents a literature review on visualization techniques in NTE 
applications. Specifically, the techniques of electron microscopy, CLSM, and μCT are 
examined, with the current and potential future applications of these techniques to 
understand properties of native tissues and tissue-engineered constructs in NTE. 
  Chapter 3 presents an investigation into the addition of laminin to chitosan 
scaffolds for promoting axon guidance in cultured adult dorsal root ganglion (DRG) 
neurons. Using the DBRP technique, 2D grid patterns were created by chitosan or 
laminin-blended chitosan substrate strands oriented in orthogonal directions; adult 
DRG neurons were selected and cultured on the patterns in vitro. The effect of the 
patterns on the orientation of neurite growth was investigated after 4 days of neuron 
culture.  
  Chapter 4 presents the development of a novel 3D scaffold made from a mixture of 
chitosan microspheres (CMs) and PLLA by means of the RFP technique. The 
microstructure, mechanical properties, and chemical characteristics of the 
16 
 
PLLA/chitosan scaffolds were evaluated. Also, the protein release rate of the scaffolds 
were studied. 
  In Chapter 5, the in vitro degradation of the PLLA/CMs scaffolds were investigated. 
The degradation properties of the scaffolds were characterized by using μCT, weight 
loss, Raman spectroscopy, and differential scanning calorimetry.  
  Chapter 6 presents a study on exploring the potential of x-ray diffraction enhanced 
imaging (DEI) as a novel method for the visualization of low-density polymer 
scaffolds in soft tissue. DEI can clearly visualize scaffolds embedded in unstained 
muscle tissue, as well as the microstructure of muscle tissue. The potential for the use 
of DEI in soft tissue engineering is discussed.  
  Chapter 7 presents the conclusions drawn from this research. This is followed by 
suggestions and recommendations for possible future work. 
 
1.5 Contributions of the Primary Investigator 
  The papers included in this thesis are co-authored; however it is the mutual 
understanding of all authors that Ning Zhu, as the first author, is the primary 
investigator of the research work. The contributions of other authors are limited to an 
advisory and editorial capacity and they are acknowledged. 
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CHAPTER 2 
REVIEW: VISUALIZATION TECHNIQUES FOR NERVE TISSUE 
ENGINEERING APPLICATIONS* 
 
*This chapter has been published as "Zhu N., Chen X.B., Chapman D. (2010) A brief 
review of visualization techniques for nerve tissue engineering applications. Journal 
of Biomimetics, Biomaterials, and Tissue Engineering. 7: 81-99". According to the 
Copyright Agreement, "the authors retain the right to include the journal article, in 
full or in part, in a thesis or dissertation". 
 
2.1 Introduction 
Nerve tissue engineering applies the principles of biology and engineering to the 
development of functional substitutes for damaged nerve tissue [101, 122]. Scaffolds 
are developed through tissue engineering and employed as carriers for cells and 
biochemical factors as constructs providing appropriate mechanical conditions, or 
both. In general, the term scaffolds is used to describe all structures used to restore 
functionality of an organ either permanently or temporarily [123]. Ideally, a scaffold 
should (1) be highly porous with an interconnected three-dimensional (3D) pore 
network for cell growth and flow transport of nutrients and metabolic waste; (2) be 
biocompatible and bioabsorbable with a controllable degradation and absorption rate 
to match cell/tissue growth in vitro and/or in vivo; (3) have suitable surface chemistry 
for cell attachment, proliferation, and differentiation, and (4) match mechanical 
properties of the tissues at the site of implantation [124]. Biomedical imaging 
techniques are playing an increasingly important role in the rigorous characterization 
of engineered tissues and biomaterials. Imaging is a key means by which tissue 
engineers can determine which chemical and biological species are present in a 
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biomaterial, how those species are spatially distributed, and how long they remain 
functional. Recent advances have extended the application of sophisticated 2D and 3D 
imaging technologies to reveal complex biological events and species at 
biomaterial-tissue interfaces. 
Imaging of engineered tissues is very important due to incomplete knowledge of 
cell physiology and dynamics, especially with regard to the integration of engineered 
and host tissues. Progress in tissue engineering requires a number of technological 
innovations in imaging, including (1) non-invasive, real-time methods to continuously 
monitor cell differentiation, scaffold degradation, and tissue replacement; (2) 
label-free techniques with comparable sensitivity techniques using labels at molecular 
and cellular levels; (3) ways to identify and track individual cells and cell 
subpopulations in vivo; (4) processes to image cells at deeper levels within tissues and 
organs; and (5) 3D image analysis and quantification [125]. 
In this article, the application of several visualization techniques in nerve tissue 
engineering is reviewed, including electron microscopy, confocal laser scanning 
microscopy (CLSM), and micro-computed tomography (μCT). The current and 
potential future application of these techniques to understand properties of native 
tissues and tissue-engineered constructs are also discussed. 
 
2.2 Electron Microscopy  
2.2.1 Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) has become a standard visualization method 
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for morphology elucidation, and is widely used in nerve tissue engineering for the 
characterization of engineered scaffolds. SEM images can reveal morphological 
features of scaffolds [126, 127] and allow direct measurement of the pore size [128], 
fiber diameter [129], and microsphere diameter [130]. Visual estimates of 
interconnectivity, cross-sectional area, and anisotropy can also be obtained [131, 132]. 
SEM imaging results can help to determine how scaffolds degrade [133], and this 
technique can also be used to observe morphological feature of cell attached to 
scaffolds, thus contributing to an understanding of cell-substrate interactions. SEM 
images are usually employed to study the attachment of nerve cells as well as surface 
spreading of different polymers [134]. For example, Bozkurt et al. observed the 
orientation of Schwann cells on the 3D-collagen scaffolds by means of SEM [135].  
With the evolution of SEM techniques, applications for nerve tissue engineering are 
expanding. Environmental scanning electron microscope (ESEM) can be used with 
non-conductive samples; cells and materials samples do not require 
desiccation/dehydration and coating with gold [136]. ESEM could solve the problems 
with respect to the invasive preparation process of SEM, which may lead to 
incomplete results or unclear images. Recently, Martinez et al. reported that the 
combination of focused ion beam (FIB) lithography with scanning electron 
microscopy (SEM) in a double-beam apparatus makes in situ imaging of sample 
cross-sections possible in well-defined areas [137]. With the SEM/FIB technique, a 
given cell growing on the polymer substrates can be selected for analysis, and high 
resolution imaging of localized cross-sections of the cell can be achieved. Greve et al. 
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investigated substrate-induced effects on neuronal networks (Figure 2.1) [138]. The 
SEM/FIB allowed them to obtain the cross-section images of the selected neurites and 
neurons, demonstrating that the neuron attachment to the surface is discontinuous as 
regions of tight attachment alternate with cavities. This type of study would be 
extremely difficult using conventional SEM techniques. The SEM/FIB technique 
could be beneficial for revealing the interactions between nerve cells and the scaffold 
surface. 
 
Figure 2.1. Images show chicken dorsal root ganglion neurons forming networks on 
laminin-111 (a, c, and e) and the sixth immunoglobulin domain of cell adhesion 
molecule L1 (L1Ig6) (b, d, and f) substrates analyzed by in situ focused-ion-beam 
milling followed by SEM (SEM/FIB). Figures (a) and (b) show an overview of the 
neuronal network; (c) and (d) show cross sections by in situ focused ion-beam milling 
through selected neurites extending on the substrates. Cross-sections through neuronal 
cell bodies on laminin-111 and L1Ig6 are shown in (e) and (f). (from [138])4 
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2.2.2 Transmission electron microscopy (TEM) 
Another electron microscopy technique widely used in biology and materials 
science is transmission electron microscopy (TEM). This method can obtain images 
with a spatial resolution of less than 1 nm, which enables the observation of 
regenerative nerve tissues at the cellular level. Specimens for TEM analysis must be 
thinner than about 100 nm for electron transmission to occur effectively. After 
staining, TEM is routinely used to visualize nerve tissues at the nanometer scale, 
including the detailed structure of myelin sheaths, Schwann cells, and axons [139, 
140]. Combined with immunostaining methods, TEM images can distinguish some 
specific structures in nerve tissues [141]. In addition, TEM imaging can be used for 
reconstruction of small, highly detailed sample volumes by tilting ultrathin slices 
[142]. 
 
2.3 Confocal Laser Scanning Microscopy (CLSM) 
Confocal laser scanning microscopy is a technique for obtaining high-resolution 
optical images with depth selectivity [143]. The key feature of confocal microscopy is 
its ability to acquire in-focus images from selected depths, a process known as optical 
sectioning or tomography. Images are acquired point-by-point and reconstructed with 
a computer, allowing three-dimensional reconstructions of topologically-complex 
objects. In effect, CLSM achieves a controlled and highly limited depth of focus. The 
penetration depth of CLSM can be from 10 to 300 μm. 
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2.3.1 Visualization of 3D samples 
With advances in tissue engineering, more and more researchers are focusing on 3D 
culture in vitro experiments instead of 2D experiments, because 3D culture may be of 
more physiological relevance as in vivo due to the marked differences between cells 
cultured in 2D and 3D [144, 145]. When normal light or fluorescence microscopy 
becomes limited, confocal microscopy - a widely available tool - has gained 
popularity for 3D researches of  engineered tissues, including cartilage [118], bone 
[146], and vascular [147]. In nerve tissue engineering, CLSM offers excellent 
possibilities to control the depth of field of scanning for monitoring 
fluorescent-stained neuronal structures at sub-micrometer resolution in 3D structure 
environments. Patz et al. reported B35 neuronal cells grew in a 3D substrate and 
formed a 3D neural network, which was captured by using CLSM at the depths up to 
75 μm [148]. Smeal et al. used CLSM imaging results to determine that the substrate 
curvature influences the direction of nerve outgrowth [111]. Confocal images can also 
provide the evidence regarding the differences between morphologies of neuronal 
growth cones cultured in 2D and 3D environments [149].  
 
2.3.2 3D image reconstruction 
 3D image reconstruction is another powerful function of CLSM techniques. With 
recent developments in fabrication, various 3D scaffolds with designed hyperfine 
microstructures are being applied to neuron culture and axon guidance, including 
those with groove/ridge type micropatterns [150] and 3D hydrogel patterns [151, 152]. 
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The 3D images obtained by means of CLSM aid not only in the evaluation of 3D 
structural features of the designed scaffolds [152], but also contribute to 
understanding the effect of topographic features of the 3D scaffolds on neurite 
outgrowth (Figure 2.2) [150].  
 
Figure 2.2. The CLSM images show the neurons growing on the groove/ridge type 
topography substrates that were ‘buried’ under a monolayer of astrocytes for up to 3 
weeks. Cultures were immunolabeled with axonal (red) and myelin (green) markers 
after 3 weeks in culture. The microgrooves were visualized by reflection of the laser 
line (blue). Myelinated axons were found both within grooves (arrow) and on ridges 
(asterisk). (from [150])5 
 
2.3.3 Applications for in vivo studies 
In vivo confocal microscope techniques are also employed in neuroscience and 
tissue engineering [153, 154]. In corneal tissue engineering, confocal microscopy has 
been utilized to assess cell and nerve ingrowth at the full-thickness of corneal tissue in 
live animals. Lagali et al. used in vivo confocal microscopy to evaluate corneal nerve 
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regeneration [155], where imaging results enabled the quantification of nerve 
parameters, including nerves number, density, and diameter.  
 
2.3.4 Applications in drug delivery research 
Coupled with fluorescence techniques, CLSM provides a comprehensive tool for 
the investigation of drug delivery [156]. After fluorescently-tagged bioactive 
molecules are encapsulated into micro- or nano-sized drug carriers, CLSM can be 
used to visualize the bioactive molecules in a 3D drug delivery system. CLSM can be 
applied to different drug carrier systems, such as film coatings, microspheres, and 
hydrogels [157]. For example, Piotrowicz et al. fabricated microspheres loaded with 
fluorescein isothiocyanate-labeled bovine serum albumin (FITC-BSA) instead of 
nerve growth factor and loaded them into the nerve guidance channels; their 
distribution within the wall structure was characterize using CLSM [35].  
 
2.3.5 Applications to assess scaffold degradation  
With the development of fluorescence techniques, characterizing degradation of 
tissue engineered materials using confocal imaging is now possible. Recently, Ballios 
et al. studied the in vivo degradation of the fluorescence-labeled 
hyaluronan/methylcellulose (HAMC) scaffolds by means of the 3D reconstructions of 
this injectable scaffold from the confocal images in the sub-retinal space (Figure 2.3) 
[158]. After the scaffolds were injected into the sub-retinal space of adult mice, they 
could be visualized by confocal microscopy both immediately and successively over 
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time to determine the degradation profile. During the degradation process, the 
fluorescence can be quantified by image analysis software. Furthermore, the 
degradation processes of some scaffold materials (such as poly(lactic-co-glycolic acid) 
(PLGA) [159]) lead to a change in pH. Thus, pH-sensitive fluorescent dyes can be 
coupled with these types of materials; as the materials degrade, they can be imaged 
using CLSM and the micro-environmental pH value can be measured. These image 
results can aid in the study of degradation properties of scaffold materials. Therefore, 
confocal microscope techniques show great potential as a non-destructive tool for the 
study of scaffold degradation. 
 
Figure 2.3. In vivo degradation characterization of the fluorescently labeled 
hyaluronan (HA)/methylcellulose (MC) blended material in the sub-retinal space. (a) 
Mass loss curves (% remaining) of HA (□) and MC (●) over 7 days as assessed by 
confocal microscopy of fluorescently-labeled components. The fluorescence intensity 
was quantified. Representative images are shown from HA (b, c) and MC (d, e) 
degradation time courses. Confocal reconstructions are over an area of 1.3×1.3 mm of 
tissue, with tissue thickness (t) as indicated. (from [158])6 
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2.3.6 Prospective 
CLSM imaging techniques have great promise for future applications in nerve 
tissue engineering. Development of new technologies may further increase the 
sensitivity, spatial resolution, and functionality of CLSM imaging in nerve 
regeneration processes. One advance in this area is the improvement of 3D 
reconstruction based on time-lapsed observation of live tissue. Du developed a 
fully-automated, non-rigid, intensity-based registration method to improve 3D 
reconstruction and subsequent visualization and quantitative analysis of fluorescently 
labeled live tissues using CLSM [160]. This improvement may be applied to the real 
time observation of dynamic changes in neuron outgrowth in 3D environments. 
Another advance comes from the development of fluorescence techniques. For 
example, obtaining voltage imaging of membrane potential in dendrites and axons of 
neurons by combining voltage-sensitive staining techniques with CLSM is now 
possible [161]. This non-invasive imaging technique may aid in the study of the 
electrophysiological behavior of neuron regenerative processes.  
 
2.4. Micro-computed tomography (μCT) 
2.4.1 Development of the μCT techniques 
Computed tomography (CT) is a powerful non-destructive technique for producing 
3D images that reveal the microstructure of objects [162]. In recent years, CT has 
become a widely applied tool in science and medicine [163-165], where it supports 
both clinical practice and fundamental research in areas including tissue engineering 
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[124, 166]. Conventional CT (such as medical) scanners are not suited for the study of 
objects at high resolution due to their large focal spot. Thus, micro-computed 
tomography (micro-CT or μCT) scanners have been developed predominantly for use 
in research applications. [167-169]. Desktop μCT systems provide nominal 
resolutions ranging from 5 to 100 μm, and specimens with diameters ranging from a 
few millimeters to 100 μm can be measured. However, the maximum power of the 
x-ray source is limited with a consequent upper limit to the available flux. 
Synchrotron facilities, especially third generation synchrotron facilities, can now 
generate x-ray photon fluxes several orders of magnitude higher, with high brilliance, 
small angular beam divergence, high level of polarization and coherence, low 
emittance, and the possibility for monochromatization [170, 171]. Synchrotron-based 
micro-computed tomography (SRμCT) can achieve quantitative images with high 
spatial resolution (1 to 10 μm) and signal-to-noise ratios [172]. This technique is well 
developed in medical and materials science for structural sizes down to several 
micrometers and is considered non-destructive and non-invasive with substantial 
potential for nerve tissue engineering applications. 
 
2.4.2 Characterization of scaffolds 
μCT techniques are becoming increasingly important for the visualization and 
analysis of tissue engineered scaffolds due to the advantages of non-destructive and 
non-invasive analysis and 3D image reconstruction. The architectural features of 
engineered scaffolds are studied after the design and fabrication process so that the 
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success and precision of the process can be assessed. The architectural characteristics 
of scaffolds include porosity, pore size, surface area to volume ratio, interconnectivity, 
anisotropy, strut thickness, cross-sectional area, and permeability [173, 174]. The pore 
structure of scaffolds is important for cell survivability and the pore network is used 
for molecular transport [175], including the exchange of oxygen, nutrient, metabolic 
wastes, and molecular signaling that are essential for cell migration and proliferation. 
When molecular transport is hampered due to poor diffusion, cell-scaffold constructs 
exhibit peripheral cellular growth while the interior of the construct undergoes 
necrosis [176]. These principles are also relevant for the design of nerve tissue 
engineered scaffolds applied in peripheral or central nerve regeneration.  
Scaffolds with intricate interior structures can be visualized using μCT, as any 
spatial location of the architecture can be digitally isolated; this is a key advantage 
over conventional techniques, such as electron microscopy. Within the digital-excised 
scaffold cube, scaffold material volume and surface area can be measured, thus the 
porosity pore size, interconnectivity, anisotropy, strut thickness, and the surface area 
to volume ratio can be calculated. μCT imaging allows the user to select any specific 
location as a region of interest (ROI) where visualization of 3D pore shape and 
measurement of pore parameters can be conducted (Figure 2.4). To date, μCT 
techniques have been widely used to analyze the features of porous structure of the 
3D scaffolds in tissue engineering. In nerve tissue engineering, for example, Silva et 
al. recently developed a 3D tubular structure scaffold for the applications to spinal 
cord injury regeneration and characterized the scaffolds using μCT technique [177].  
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Figure 2.4. Micro-CT 3D images for a pure poly (L-lactic acid) (PLLA) scaffold (A) 
and a PLLA-chitosan hybrid scaffold (B). The variation of the porosity along the 
thickness of the scaffolds for the two analyzed structures is represented in the graph 
(C). (from [178])7 
  
2.4.3 Potential for μCT techniques in nerve tissue engineering 
Conventional methods to study tissue-scaffold interactions use optical or 
transmission electron microscopy after histological sectioning, which involves many 
individual steps including fixation, embedding, sectioning, staining, and mounting [26, 
179]. Each step can result in losses due to artifact production during preparation 
and/or in the process of rendering the complex 3D structures on 2D media [180]. For 
example, scaffolds may separate from their original position in the surrounding tissue. 
In the pilot in vivo experiment, a histological section image of a polycaprolactone 
(PCL) nerve conduit scaffold was obtained, which was used to bridge the sciatic nerve 
of an adult rat for 7 days (Figure 2.5). During frozen sectioning for histological 
staining, scaffolds embedded in nerve tissues can easily crack, transform, and move 
away from the surrounding tissues due to differences in hardness and plasticity 
between the synthetic materials and the tissue. Consequently, observing structural 
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changes in the degrading scaffolds as well as the reciprocal effects between scaffolds 
and tissues in vivo using histological methods are challenging. μCT is nondestructive 
and non-invasive, and therefore has significant advantages over histological methods, 
including the ability to study the samples over time or keep them intact for additional 
assessments. The quality of the data is also increased, because interventions can be 
assessed on an animal-specific basis; each animal acts as its own control and can 
demonstrate individual response characteristics, thereby eliminating the problems of 
cross-sectional studies. Moreover, the non-destructive aspects allow this method to be 
used to screen scaffolds before implantation, so only those that fulfill certain criteria 
are employed. Komlev et al. [164] used SRμCT to qualitatively and quantitatively 
evaluate tissue engineered bone growth kinetics in 3D porous scaffolds during 
implantation experiments. Hagenmuller et al. [181] quantitatively assessed the 
formation of bone-like tissue in the designed scaffolds using non-invasive time-lapsed 
μCT, and verified that μCT irradiation dose not impact the osteogenic performance of 
the stem cells based on a series of biochemical tests.  
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Figure 2.5. Histological section of a PCL scaffold implanted into an injured sciatic 
nerve of a rat for 7 days. The tissues are stained with purple color; the arrow shows 
the PCL scaffold.8 
 
Although, μCT techniques have been successfully and widely used for the studies 
of bone engineered scaffolds [182-184] and bone tissue regrowth [164, 181, 185] in 
vitro and in vivo in recent years, there have so far been few applications of μCT 
techniques to nerve tissue engineering. The primary obstacle is the low attenuation 
contrast of nerve tissue or scaffold samples. The principle of μCT techniques is 
largely based on the absorption contrast of imaged objects; objects with high 
absorption contrast can result in high quality μCT images. However, the density of 
nerve tissue and nerve engineered scaffold materials are both very low and similar, so 
32 
 
distinguishing them by using μCT techniques is difficult. With the combined 
availability of x-ray staining techniques and x-ray phase contrast techniques, there 
will be predict further advances in μCT techniques for nerve tissue engineering. 
 
2.4.3.1 X-ray staining techniques 
Neurons, nerve fibers, nerve tissue engineered scaffolds, and surrounding soft 
tissues have small differences in density. Thus, they exhibit almost no difference in 
x-ray absorption and are essentially invisible using conventional μCT, especially in a 
hydrated environment. Highly x-ray absorptive contrast agents with a high atomic 
number can be used to produce sufficient contrast in the acquired tomograms. These 
x-ray staining techniques are helpful for obtaining images to inform scaffold 
fabrication protocols and assess nerve tissue engineered scaffold architecture and the 
formation of new nerve tissues. Various dyes can be applied to stain soft tissues or 
some low density scaffold polymers for this purpose.  
Osmium tetroxide (OsO4) is a highly x-ray absorptive agent used for x-ray contrast 
enhancement in cells and soft tissues [186, 187], commonly used to prepare tissues for 
electron microscopy. It reacts with the unsaturated fatty acids and therefore increases 
the x-ray absorption of cell membranes. Nerve tissue can be stained with OsO4 for 
visualization with x-rays. Lareida et al. used SRμCT technique to visualize the 
osmium-stained the nerve fiber network within the basilar membrane [188]. The 
high-quality 3D images exhibit the complex 3D morphology of the nerve fiber 
bundles, which are difficult to extract from histological slices (Figure 2.6). OsO4 has 
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also been used to visualize scaffold architecture using x-rays [189]. However, the 
major disadvantage of OsO4 as a staining agent is its toxicity.  
 
Figure 2.6. The reconstructed 3D SRμCT image using OsO4 as a contrast agent 
exhibits the complex 3D morphology of the nerve fiber bundles in the human cochlea. 
The semi-automatic, intensity-based segmentation of the nerve fibers as given in the 
middle panel shows the spatial distribution of the fiber bundles. The orientation of the 
2D slices is indicated in red in the 3D image and by A-A’ and B-B’ in the 2D slices. 
(from [188])9 
 
Lyophilic salts, such as CaSO4, SrSO4 and BaSO4, enable the visualization of 
microvasculature in tissues [190, 191]. They are strongly hydrophobic and inert, and 
are injected into blood vessels using perfusion methods. Iodine, OsO4, and lead 
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chromate can also be used to visualize blood vessel systems. The combination of 
contrast agents with μCT techniques can be used to not only show the complex 3D 
microvascular network architecture but also quantify vessel volume, thickness, 
number, connectivity, and degree of anisotropy [192]. The techniques show promise 
for the study of neo-vascularization in regenerative nerve tissues. Recently, Bolland et 
al. visualized the new blood vessel formation in poly (DL-lactic acid) scaffolds in vivo 
by means of lead chromate staining [193]. Briefly, the technique involves perfusion of 
a radio-opaque silicone rubber contrast agent containing lead chromate (Microfil 
MV-122, Flow Tech; Carver, MA) through the vasculature immediately following 
euthanasia. This technique has primarily been applied in small animal models. 
Gold is another important contrast agent. Thurner et al. used gold-labeled lectin to 
stain foreskin fibroblasts and osteoblast-like cells for 3D morphology studies of cells 
on polymer scaffolds using SRμCT, because lectins can bind to sugar residues or 
derivatives on the cell membrane [194, 195]. From the acquired 3D data, the total cell 
volume, total cell volume density, and cell mass distribution can be quantified [196]. 
With respect to nerve tissue engineering, CLSM is of great value for cell imaging, but 
SRμCT seems to be the method of choice if quantitative 3D information is needed; 
this is especially true if opaque scaffolds are used. Furthermore, gold is a very useful 
contrast agent for biological systems research. Not only is it chemically inert and 
non-toxic, but it does not interfere with the normal cell function; the surfaces of gold 
nano-particles are also easily coated with a variety of proteins to provide some 
functional behavior in a biological environment [197]. Hall et al. reported that the 
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gold-loaded glioma cells permitted 3D visualization of the cells within bulk tissue 
using SRμCT technique [198]. Therefore, the features of gold make it useful in the 
investigation of the proliferation and migration of labeled cells implanted in vivo. 
 
2.4.3.2 Synchrotron-based phase-contrast techniques 
Synchrotron radiation, producing x-rays with higher photon flux and greater spatial 
coherence than standard computed tomography, has great potential for the 
development of new imaging methods. Synchrotron-based phase contrast techniques 
allow structural visualization of low density scaffolds and nerve tissues without 
fixation, sectioning, and staining. 
 
(1) In-line phase contrast micro-tomography (PC-μCT) 
In-line phase contrast technique is one of the x-ray phase contrast techniques. The 
image contrast principle of x-ray phase contrast techniques, briefly, is effectuated by 
local alterations of the x-ray refractive index n(x', y', z') causing phase changes of the 
x-ray wave upon passing through the sample [199]. The phase changes of the x-ray 
will be reflected on images as the edge enhancements for the different components of 
the samples. The amount of edge enhancement depends on the distance between the 
sample and detector, the x-ray energy, the resolution of the detector, and the phase 
properties of the sample. By combining in-line phase contrast techniques with 
micro-tomography, in-line phase contrast micro-tomography (PC-μCT; Figure 2.7) 
may be useful in nerve tissue engineering research.  
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Figure 2.7. Schematic representation of the in-line phase contrast microtomography 
(PC-μCT). SR is the synchrotron radiation source. The distance between the object 
and detector is usually in a range from tens of centimeters to several meters. A large 
sample-detector distance can enhance the bending of beam (refraction) and thus 
results in sharper contrast near the edges. 10 
 
Beckmann et al. acquired the 3D structural images of the unstained rat trigeminal 
nerves using PC-μCT, and a pattern of nerve fibers can be seen in the images [200]. 
Kim et al. used a third generation synchrotron radiation facility for the visualization of 
normal and damaged rat sciatic nerve without fixation and staining, and obtained the 
high resolution PC-μCT images [201]. The structures with small density differences, 
such as nerve fibers and surrounding tissues, were successfully imaged due to the 
attenuation of phase boundaries. Each nerve fiber could be easily discriminated and 
the arrangement of nerve fibers could be identified. However, the axons in each nerve 
fiber were still invisible due to the spatial resolution limitation of the PC-μCT images. 
Recently, Zehbe et al. reported inspiring results on the 3D morphological 
characterization of articular cartilage using PC-μCT [86]. The cell number/cell density 
(Figure 2.8) and the shape and orientation of the cells inside the cartilaginous part of 
the sample were quantitatively analyzed based on the 3D PC-μCT images. 
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Figure 2.8. (a) Quantitative analysis from a 3D PC-μCT image for cell density in a 
0.256 mm3 volume of the soft tissue region of freeze dried articular cartilage. (from 
[202])11 
 
(2) Diffraction enhanced tomography (DEI-CT) 
X-ray diffraction enhanced imaging (DEI; Figure 2.9) is another phase contrast 
technique based on differences in the x-ray refractive index distribution of an object; 
this method is more sensitive to relative differences between materials at certain x-ray 
energies than the absorption contrast method [203, 204]. Pure refraction contrast 
information of samples can be extracted by DEI analysis. The resulting refraction 
contrast image represents the spatial gradient of the refractive index, enhancing and 
highlighting edge appearance, contours, and interfaces of different tissues and 
materials.   
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Figure 2.9. Schematic representation of the experimental setup for diffraction 
enhanced imaging and radiography (absorption imaging). The coordinate system is 
indicated near the object. The incident x-ray beam travels along the y direction, the 
object is scanned along the z direction, the image of the object is formed in the x - z 
plane, and the diffraction plane of the monochromator-analyzer crystal is the y - z 
plane. The detector is shown in two alternate positions: the upstream location is for 
radiography; the downstream location is for DEI. (from [205])12 
 
To date, DEI has been used to visualize liver [206, 207], breast [208], bone [209], 
and non-calcified tissues [210] including tendons, ligaments, adipose tissue, and 
cartilage. In the refraction images of normal liver tissue, vessel walls and vessel trees 
can be clearly distinguished down to small branches (tens of micrometers in diameter); 
this level of detail would not be achievable in a conventional absorption contrast 
image [206]. In a pilot experiment to visualize a low density biodegradable polymer, 
the DEI images of several low density polymers were produced, which have been 
used in nerve tissue engineering including poly (L-lactic acid) (PLLA) (block), 
polycaprolactone (PCL) (block), alginate (filaments), and chitosan (filaments) (Figure 
2.10); the edges and shape of the scaffolds are clearly visible. The detailed structural 
information of the samples in the refraction angle images (Figure 2.10a-d) is greater 
than in the absorption images (Figure 2.10e-h). These results demonstrate the 
potential to visualize the microstructure of scaffolds using the DEI technique in vitro. 
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Figure 2.10. SR-DE images of PCL, PLLA, alginate filament, and chitosan scaffolds. 
(a,e) PCL, (b,f) PLLA, (c,g) alginate, (d,h) chitosan; (a-d) refraction angle images, 
(c-h) absorption images.13 
 
Combined with tomography techniques, x-ray diffraction enhanced tomography 
(DEI-CT) might be used to obtain 3D structural features of low density scaffolds and 
regenerative nerve tissues. The advantage of DEI-CT images is the capacity to 
provide detailed structural information. Bravin et al. visualized breast tissue using a 
SR-DEI-CT technique [211], where the DEI-CT images showed very rich detail 
corresponding to the structures of the histological section, even thin collagen strands 
(Figure 2.11). Another advantage of DEI-CT technique is that the radiation dose 
deposited in a given specimen by DEI-CT during scanning is less than that by desktop 
μCT techniques. The DEI extinction contrast of subjects can be large at high x-ray 
energies; higher energy means less absorption and a lower dose to the sample or 
subject [204, 212]. Therefore, compared with desktop μCT, the radiation dose may be 
reduced by an order of magnitude without compromising image quality. Reducing the 
dose in DEI-CT scanning is very important for in vitro and in vivo studies to prevent 
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structural and chemical changes that may occur due to x-ray exposure during the 
scanning process. Furthermore, repeat μCT scans of the same sample after removing 
some histological sections for comparison could be of interest. Under low dose 
scanning, DEI-CT can visualize scaffolds and regenerative tissues in living animals 
and may represent the next significant advance for in vitro and in vivo nerve tissue 
engineering studies. 
 
 
Figure 2.11. Comparison of the DEI-CT image and conventional images for the 
visualization of the breast tissue (a) Scanner image of the histologic whole-mount 
slide from a breast tissue sample with ductal carcinoma. The nuclei are shown in 
brown or black, young collagen and reticulin in bluish, mature collagen in red, 
adipocytes in white, and both red blood cells and muscle in yellow; (b) clinical screen 
film mammogram of the same sample; (c) clinical computed tomography (CT) image 
of the same sample; (d) DEI-CT top image of the same sample. (from [211])14 
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2.5 Conclusions  
Various visualization techniques play important roles in nerve tissue engineering 
studies. Some conventional visualization techniques, such as light microscopy, CLSM, 
and SEM, have been widely used to understand nerve tissue regeneration, analyze the 
morphological features of nerve tissue engineered scaffolds, and reveal the interaction 
of cells and biomaterials. To meet the demands of the evolving area of nerve tissue 
engineering, the conventional visualization techniques need to be improved by 
coupling other techniques, such as staining techniques and tomography methodologies. 
The improvements can provide images with higher resolution, allow imaging of 3D 
structure of samples, and improve the ability of quantitative analysis based upon 
imaging results. 
μCT techniques have been employed in tissue engineering research, 
complementing conventional visualization techniques rather than competing with 
them. They provide an excellent non-destructive and non-invasive method for 
analyzing the structure of engineered scaffolds. This structural characterization detail 
is not afforded by other conventional porosity analysis techniques. μCT also offers the 
unique capacity to analyze tissue growth in porous scaffolds both in vitro and in vivo. 
With the development of x-ray staining and synchrotron light source techniques, low 
density scaffold materials and soft tissue can be visualized and qualitative and 
quantitative analysis by μCT. μCT techniques show great potentials in nerve tissue 
engineering studies, especially in real-time studies in living animals. 
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Selection of a suitable visualization technique to characterize scaffolds and tissues 
involves weighing the virtues and pitfalls associated with each technique. No 
visualization technique stands alone, but should be conducted in concert with others to 
better serve nerve tissue engineering research and help further our understanding 
regarding nerve regeneration.  
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CHAPTER 3 
EFFECTS OF LAMININ BLENDED WITH CHITOSAN ON AXON GUIDANCE 
ON PATTERNED SUBSTRATES* 
 
*This chapter has been published as "Zhu N., Li M.G., Guan Y.J., Schreyer D.J., 
Chen X.B. (2010) Effects of laminin blended with chitosan  on axon guidance on 
patterned substrates. Biofabrication. 2(4): 045002". According to the Copyright 
Agreement, "the authors retain the right to include the journal article, in full or in part, 
in a thesis or dissertation". 
 
3.1 Introduction 
In nerve tissue engineering, axon guidance is crucial to successful functional nerve 
regeneration [101, 108]. Axon growth and guidance may be mediated by many 
permissive factors, including biocompatible scaffold biomaterials [71, 109, 110], 
growth-promoting and signaling molecules [112-114], the influence of chemical 
gradients [115], and fabrication of a rationally designed microstructure [111]. 
However, conventional techniques for manufacturing scaffolds, including solvent 
casting and particulate leaching [79], gas foaming [213], fiber meshes and fiber 
bonding [214], and phase separation [215] offer little capacity to precisely control the 
internal structure and biochemical features of scaffolds. To achieve more precise 
microstructural features, various rapid prototyping (RP) techniques have been used in 
recent years for tissue engineering scaffold fabrication [216-218]. Among them, 
dispensing-based rapid prototyping (DBRP) is a promising method by which 
biomaterials in a fluid form are delivered to build scaffolds in a controllable manner 
[216]. Specifically, biomaterials are continuously extruded from a needle and 
deposited on substrates, forming 2-dimensional (2D) or 3-dimensional (3D) strand 
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micropatterns of scaffolds [216, 219]. DBRP offers an efficient approach to create 
such micropatterns with complex 2D or 3D architectures and chemical subdomains, 
which, notably, may not be producible by means of conventional lithographic 
methods. 
Chitosan is a natural biological polymer that has been widely studied for tissue 
engineering scaffolds applications, including reconstruction of bone [220], 
vasculature [221], liver [222], and other tissues, because of its mechanical properties, 
biocompatibility, and biodegradability [223-225]. The cationic nature of chitosan also 
contributes to the retention and concentration of growth factors secreted by colonizing 
cells [226]. Chitosan also has good cytocompatibility for neural growth [227], making 
it a good candidate for promoting the repair of peripheral nerves. However, chitosan 
does not have any specific bioactivity to interact with neurons for the purpose of axon 
guidance in nerve regeneration. This problem can be solved by material modification 
methods. One effective method for synthesizing new composite materials for 
particular tissue engineering applications is polymer blending [30, 228], which is very 
suitable for use with the DBRP technique. By blending with other materials, chitosan 
can be imbued with desired functional properties [109].  
Laminin is an extracellular matrix (ECM) adhesion protein, which appears to be an 
important guidance signal molecule for developing axons in vivo [229]. It also 
demonstrates a neurite-promoting activity in tissue culture, and can stimulate the 
mitosis of the Schwann cells that form myelin around mature axons in the peripheral 
nervous system (PNS) [230].  
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  In this study, chitosan was blended with laminin to support and guide neurite 
growth in a tissue culture model. Adult dorsal root ganglion (DRG) neurons were 
selected for cell culture and analysis. The axons of DRG neurons are a major 
component of PNS nerves. Moreover, DRG neurons can be cultured from adult 
(rather than embryonic) animals, and therefore serve as a better model for 
regenerative (rather than developmental) axon growth and guidance. 
The uniform 2D surfaces were first examined, then more complex 2D 
micropatterns. The aim was to determine the effect of the microenvironment of 
axon-materials affinity difference on axon guidance. If the method is validated and 
applied to the design of 3D nerve conduit scaffolds, materials demonstrating axon 
affinity may effectively guide the directional growth of axons and help to realize the 
functional recovery of peripheral nerve injury.  
 
3.2 Materials and Methods 
Chitosan (28191), laminin (L2020), and poly-l-lysine (P9155) were purchased from 
Sigma-Aldrich Canada and used as received to prepare stock solutions, chitosan 
powder was dissolved at 3% (w/v) concentration in 2% acetic acid by stirring 
overnight, then sterilized by exposure to 6.5 KGy gamma irradiation. Laminin (1 
mg/ml in 50 mM Tris pH 7.4 and 0.9% NaCl) was thawed and aliquoted under sterile 
conditions. Lyophilized poly-l-lysine powder was dissolved at 25 µg/ml in deionized 
water under sterile conditions. 
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3.2.1 Fabrication of micropatterns for testing 
(1) 2D uniform surfaces 
Blended laminin-chitosan solutions at w/w ratios of 0%, 0.03% and 0.06% (denoted 
by ChLN0, ChLN3, and ChLN6, respectively) were prepared by uniformly mixing 
laminin into stock chitosan solution using a vortex mixer at 2000 rpm for 10 minutes. 
To prepare uniform 2D surfaces, glass coverslips were dipped in the ChLN0, ChLN3 
or ChLN6 solutions to form a thin film, and then dried under flowing sterile air at 
room temperature. For control comparison, poly-l-lysine (PL) coated coverslips were 
also prepared by puddling poly-l-lysine solution onto the entire surface area of the 
glass coverslips and incubating at 37°C in a 5% CO2 incubator for 4 hours. These 
coverslips were then washed three times with phosphate buffered saline (PBS) and 
dried under sterile air at room temperature. In additional preparations, poly-l-lysine 
coated coverslips and chitosan dipped coverslips were then secondarily coated with 
laminin (denoted by PL+LN and Ch+LN, respectively). Laminin solution was 
puddled onto the entire surface area of the coverslips at 4°C overnight; the coverslips 
were then washed 3 times with PBS and dried under sterile air at room temperature. 
 
(2) 2D micropattern surfaces 
A precision fluid dispensing system (C0720M, Asymtek) [216] was used to 
fabricate 2D grid patterns on glass coverslips using the different blended 
laminin-chitosan solutions: ChLN0, ChLN3, and ChLN6. A schematic illustration of 
the DBRP system is shown in Figure 3.1. The movements of the dispensers in three 
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dimensions (X, Y, and Z) and the extrusion speeds were controlled by programming. 
During the fabrication process, the ChLN0 was extruded from one dispenser, and 
either ChLN3 or ChLN6 was extruded from the other. The software first controls the 
dispenser loaded with ChLN0 solution, extruding the solution onto a glass coverslip 
to form parallel strands. The software system then controls the other dispenser 
containing ChLN3 or ChLN6 solution, extruding the solution onto the same coverslip 
to form parallel overlaying strands in the orthogonal direction. When this procedure 
was finished, the patterns on the glass coverslips were dried under sterile air at room 
temperature. 
 
Figure 3.1. Schematic diagram of the DBRP system.15 
 
3.2.2 DRG Neuron Culture 
Primary dorsal root ganglion (DRG) neurons harvested from Sprague-Dawley rats 
(approx. 250 g) were dissociated using collagenase and trypsin [231, 232] and seeded 
on the uniformly coated or the micropatterned coverslips at a density of 1600 
neurons/cm2 and cultured in Dulbecco’s Modified Eagle Medium (DMEM) +10% 
horse serum + antibiotic/antimycotic solution at 37°C in a 5% CO2 incubator for 4 
days, then subjected to immunocytochemical and microscopic analysis. 
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3.2.3 Immunocytochemistry of neurons 
Coverslips were gently rinsed with PBS. The cells were fixed in cold methanol 
(-20°C) for 30 minutes and then rinsed with PBS. The fixed cells were blocked 
against non-specific binding (PBS + 0.5% bovine serum albumin + 1% horse serum) 
for 1 hour at room temperature. DRG neurons and neurites were stained using primary 
antibody against growth associated protein-43 (GAP-43) [233] diluted 1:5000 in 
blocking solution. After rinsing with PBS + 0.05% Tween 20, Cy3-conjugated 
anti-mouse IgG (Jackson Immuno Research) diluted 1:300 in blocking solution was 
applied as a secondary antibody for 60 min at room temperature. The DNA binding 
dye 4’,6-diamidino-2-phenylindole (DAPI) was used to stain the cell nuclei. 
 
3.2.4 Characterization of patterns 
A Zeiss Axioskop microscope was used to examine the 2D grid patterns created on 
the coverslips. Chitosan strands and the cultured cells were observed using 
phase-contrast microscopy. Immunofluorescence for laminin was then used to 
visualize the ChLN3 and ChLN6 strands. Briefly, the coverslips were blocked against 
non-specific binding (PBS + 0.5% bovine serum albumin + 1% horse serum) for 1 
hour at room temperature. Laminin was stained using an anti-laminin antibody 
(Sigma-Aldrich L9393) diluted 1:200 in blocking solution. After washing with PBS + 
0.05% Tween 20, Cy2-conjugated anti-rabbit IgG (Jackson Immuno Research) diluted 
1:300 was applied as a secondary antibody for 60 min at room temperature, followed 
by washing with PBS + 0.05% Tween 20. 
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To study the variation of the surface height at the overlapping boundary of two 
orthogonal strands, images of the topography of the grid patterns at an intersection 
were captured by means of an atomic force microscope (AFM) (Agilient 4500, 
Agilent Technologies) operating in intermittent contact mode. A silicon cantilever 
(Applied NanoScience) with a force constant of 48 N/m and resonant frequency of 
approximately 190 kHz was used. All measurements were performed at ambient 
conditions with the instrument mounted on an Olympus microscope located on a 
floating air table. 
The infrared spectra of ChLN0 and ChLN6 films were measured with an FTIR 
(FT-IR 4100, JASCO) spectrophotometer. Each spectrum was acquired in ATR 
(attenuated total reflection) by accumulation of 32 scans with a resolution of 4 cm-1 in 
the spectral range of 4000 - 400 cm-1. 
 
3.2.5 Image analysis 
To evaluate neuron viability and the length of growing neurites on the uniformly 
coated coverslips, images of the neurons were captured with a fluorescent microscope 
(Zeiss Axioskop). For each type of substrate, three coverslips were examined and the 
images were taken from 25 different locations on the coverslips. Captured electronic 
images were analyzed using Northern Eclipse 7.0 software (Empix Imaging). All 
neurons were counted based on GAP-43 staining. The lengths of GAP-43 positive 
neurites were measured using Northern Eclipse. Length analyses were conducted by: 
(1) highlighting neurites using a binary threshold, which transforms the gray level 
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image into a binary image. The binary threshold value was set based on the neurite 
size in a typical gray level image and the all the gray images were, then, transformed 
applied in the same binary threshold value; (2) ‘skeletonizing’ neurite profiles by 
reducing them to one pixel width; and (3) determining the neurite length in terms of 
the sum of the skeletonized neurite pixels. To evaluate the direction of neurite 
outgrowth on the 2D micropatterned substrates, a vector was manually measured from 
the cell body of a neuron to the tip of its neurite by means of ImageJ 1.34 software. 
The neuron cell bodies were identified based on their round shape, a cell body 
diameter of 20 µm or greater, and low density DAPI staining of their nuclei. 
The angle of each vector was expressed as deviation from 0°, the direction of the 
ChLN3 or ChLN6 strands, on fluorescent images. 
 
3.2.6 Statistical analysis 
An unpaired t-test was used to evaluate the results using Origin Pro 7.5 (OriginLab) 
software. Repeated-measure statistical analysis was employed to analyze the data for 
each of the character parameters. In all evaluations, p < 0.05 was considered to be 
statistically significant. 
 
3.3 Results 
3.3.1 ATR-FTIR spectroscopy 
Figure 3.2 shows the FTIR spectra of the chitosan containing laminin (a), the 
unmodified chitosan (b), and the pure laminin (c). The (a) and (b) FTIR spectra had 
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very similar characteristics. The absorption peaks of chitosan at about 1640 and 1553 
cm-1 were assigned to carbonyl stretching vibration of amides (amide I band) and N-H 
bending vibrations of amides (amide II band), respectively. Whereas, for the chitosan 
containing laminin, a prominent band at 1585 cm-1 was observed, which suggested 
that there were more hydrogen bonds formed in chitosan because of blending laminin. 
The amide I bond at 1621 cm-1 in the laminin FTIR spectrum (c) was not evident in 
the spectrum (a) of the chitosan containing laminin, possibly reflecting loss of the β 
sheet structure in the laminin. These findings suggest that the secondary structure of 
the laminin has been changed after being mixed into chitosan.  
 
Figure 3.2. ATR-FTIR spectrum of (a) chitosan containing laminin, (b) unmodified 
chitosan and (c) pure laminin.16 
 
3.3.2 Cell viability and length of neurites on uniform surfaces 
After 4 days in culture, DRG neurons had grown better on a uniform surface of 
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ChLN6 than on ChLN3 or ChLN0 coated coverslips. Figure 3.3(a-e) shows typical 
images of DRG neurons undergoing neurite growth. The average number of surviving 
neurons in an area of 0.7 mm x 0.5 mm on the ChLN0 coated coverslips (4.00±1.53) 
was significantly less than on Ch+LN (8.57±2.97), ChLN3 (6.28±2.51), or ChLN6 
(6.00±2.51) coated coverslips (Figure 3.3f). The differences in neuron number among 
PL+LN, Ch+LN, ChLN3, and ChLN6, however, were not significant (p > 0.05). 
Neurites growing on ChLN6 were significantly longer than that those on the ChLN3 
or ChLN0 (p < 0.01) (Figure 3.3g). There was no significant difference (p > 0.05) 
between the length of neurites grown on ChLN3 and ChLN0. The neurons grown on 
Ch+LN coverslips had longer neurites than those grown on ChLN6 (p < 0.01). These 
results indicate laminin improves the viability of neurons grown on chitosan, and the 
length of neurite growth is sensitive to the concentration of laminin blended into the 
chitosan.  
 
Figure 3.3. Cell viability and length of neurites of DRG neurons after culturing for 4 
days on uniform surfaces. (a)-(e) Immunofluorescent images for (a) PL+LN coating, 
(b) Ch+LN coating, (c) ChLN0 coating, (d) ChLN3 coating, (e) ChLN6 coating. 
Neurons and neurites (red) were stained with anti-GAP-43 and the nuclei of neurons 
and associated glial cells (blue) were stained with DAPI; (f) Mean number of neurons 
in an area of 0.7 mm x 0.5 mm; (g) Mean total neurite length/mm2. (*: p < 0.05, **: p 
< 0.01).17 
53 
 
3.3.3 2D micropattern analysis 
The grid patterns created using the DBRP system are shown in Figure 3.4. The 
width of the strands is approximately 100 µm; the parallel strands are separated by 
spaces of approximately 200 µm. The strands containing laminin (ChLN6 or ChLN3) 
were dispensed on the top of the ChLN0 strands at an angle of 90°. All strands can be 
observed under phase contrast microscopy (Figure 3.4a). With immunofluorescent 
staining for laminin, the image of the ChLN3 or ChLN6 strands is clearly seen. The 
fluorescent image also shows that laminin was uniformly distributed within the 
laminin-chitosan strands (Figure 3.4b). 
 
Figure 3.4. (a) Phase contrast image of the grid pattern on a glass coverslip, in which 
horizontal strands were made of chitosan and vertical strands are made of chitosan 
blended with laminin. (b) Immunofluorescent localization of laminin (green) within 
the same field.18 
 
AFM was used to observe the surface features at the overlapping parts between 
ChLN0 and ChLN6 strands (Figure 3.5). The variation of the surface height in the 
observed area (30 µm x 30 µm) is from 0 to 20 nm. Although previous studies 
reported that topographic features at the nano- and micrometer scale can affect the 
orientation of neurite growth [234, 235], the variation of the surface height at the 
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overlapping boundary of two orthogonal strands in this pattern model is slight and 
gentle and is unlikely to influence the orientation of neurite growth. 
 
Figure 3.5. Atomic force microscopy (AFM) topographic images of the 
ChLN0/ChLN6 grid micropatterns at the area of overlap. Scanning area: 30 µm x 
30µm. The color scale demonstrates that the topographic variance of the strand base 
material does not exceed 20 nm.19 
 
3.3.4 Directional growth of neurites 
Qualitative observations of 2D micropatterned cultures suggest that the orientation 
of DRG neurites often align with the laminin containing strands when grown on 
ChLN0/ChLM6 micropatterns (Figure 3.6a,b). To investigate this quantitatively, the 
angles of the vectors corresponding to overall direction of neurite growth were 
systematically measured and compared these vectors to the orientation of the 
laminin-free and laminin-blended strands (Figure 3.6c). These data confirm the 
qualitative impressions as a marked preference for the neurite growth vectors 
corresponding with the orientation of the laminin containing strand could be 
documented. 
55 
 
 
Figure 3.6. Immunofluorescent images showing relationship of neurites to 
laminin-containing strands. (a) DRG neurons and neurites visualized with GAP-43 
immunocytochemistry (red) after culturing for 4 days on a ChLN0/ChLN6 2D 
micropattern. Neuronal and glial nuclei are stained with DAPI (blue). (b) The same 
image is superimposed on a false color image of ChLN0 strands (grey) and ChLN6 
strands (green) positioned on a glass substrate (black). (c) Circular histogram showing 
the distribution of neurite angles on the ChLN0/ChLN6 pattern in this image. Only 
the angle of the longest neurite of each neuron is counted.20 
 
A wider sample of cultures was then surveyed, including DRG neurons grown on 
ChLN0/ChLN3 and ChLN0/ChLN6 micropatterns. In each case, the angle of the 
vector corresponding to neurite direction on the micropatterned substrates was 
measured as a deviation from the direction of the ChLN0 strand by 0° to 180° and the 
pooled results were sorted into bins. Figure 3.7a shows the distribution of neurite 
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angles on the ChLN0/ChLN3 micropatterns is random within the range from 0° to 
180°. Thus, the lower concentration of laminin does not appear to impose a 
directional preference on neurite growth. In contrast, Figure 3.7b demonstrates the 
majority of the neurite angle measurements made from cultures on the ChLN0/ChLN6 
micropatterns fell within a 20° interval around the 90° direction, which is the direction 
of ChLN6 strands. This suggests that the strands fabricated with the ChLN6 
preparation possess a biologically relevant neurite-orienting property. Observations of 
the morphology of individual neurons (Figure 3.8) suggest that the neurites growing 
along ChLN6 strands are longer than those along the ChLN0 strands. Indeed, two 
neurites from the same neuron could show a preference for longer extension on the 
ChLN6 surface (Figure 3.8a; Arrows 1, 2). Neurites also displayed a tendency to 
remain on the ChLN6 strand when confronted with a choice (Figure 3.8b; Arrow 3). 
Compared to the ChLN0/ChLN6 pattern, the neurites in the ChLN0/ChLN3 pattern 
showed a reduced tendency for strand-specific increased elongation or preference to 
grow in a certain direction (Figure 3.8c). 
 
Figure 3.7. The angle distributions of the longest neurite from each DRG neuron on 
replicate 2D micropattern substrates. (a) Distribution of neurite angles on the 
ChLN0/ChLN3 micropatterns (64 neurites from 22 different fields). (b) Distribution 
of neurite angles on the ChLN0/ChLN6 micropatterns (58 neurites from 22 different 
fields).21 
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Figure 3.8. Details of immunofluorescent images of DRG neurons after culturing 4 
days on the micropatterned substrates. (a) and (b) Neurons cultured on a 
ChLN0/ChLN6 micropattern; (c) Neurons cultured on a ChLN0/ChLN3 micropattern. 
Arrow 1 shows a neuron with a short neurite extending onto unmodified chitosan, and 
longer neurites extending onto chitosan blended with laminin. Arrow 2 shows a 
neuron with a short neurite extending onto glass, and longer neurites extending onto 
chitosan blended with laminin. Arrow 3 shows a long neurite that returns to the 
laminin environment after encountering an unmodified chitosan strand.22 
 
3.4 Discussion  
Laminin is a natural component of the extracellular matrix recognized to promote 
and guide neurite growth [236]. The main laminin receptors are integrins, which are 
located at the tips of the filopodia of migrating axonal growth cones [237]. Integrins 
may not only mediate attachment, but also transmit signals to the actin cytoskeleton 
within cells [238]. Thus, addition of laminin may improve the affinity of neurons and 
neurites for a chitosan substrate and improve, or even guide, neurite growth. Blending 
laminin into chitosan is a rapid, simple, and controllable modification method for 
scaffold fabrication. The presence of bioactive molecules on the surface and in the 
interior of the blended material scaffolds may provide positive, even necessary signals 
for cell and substrate interaction. 
In the 4-day cultures of adult DRG neurons on uniform chitosan and 
chitosan-laminin blended surfaces, better viability of the neurons on both ChLN3 and 
ChLN6 vs. ChLN0 surfaces was observed, while ChLN3, ChLN6 and Ch+LN 
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surfaces were not significantly different. This indicates laminin blended into chitosan 
at low concentrations can improve neuron survival and/or adhesion and therefore 
improve the prospects for axon growth on chitosan-based tissue engineering scaffolds 
[239]. Notably, however, no significant difference was found in how the two 
concentrations of laminin affected the survival and/or attachment of neurons in these 
initial experiments. 
The studies of neuron cultures on uniform surfaces yielded a somewhat different 
result when the effect of laminin on actual neurite outgrowth was examined. No 
significant difference in neurite length between cultures grown on ChLN0 and ChLN3 
material was found, but there was a significant increase in neurite length in response 
to the ChLN6 material containing a higher concentration of laminin. The laminin 
concentration of our ChLN3 preparation may be below the minimally effective level 
for improving neurite growth [107], even though ChLN3 could improve neuron 
adhesion compared to ChLN0. This implies that neuron cell body attachment and 
neurite elongation may be differentially sensitive to the concentration of laminin. 
In the experiments examining axon guidance, the strand size of the micropatterns 
was designed to 100 μm due to the fact that the narrower strand compared to the 
length of the neurite is able to effectively reflect the effect of the micropatterns on 
axon guidance and the minimum size of the dispenser needle available in the Asymtek 
system is 100 μm. The oriented growth of neurites was clearly observed in the 
ChLN0/ChLN6 pattern, but not in the ChLN0/ChLN3 pattern. For scaffolds 
fabricated with micropatterned laminin, this result implies that a minimum 
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improvement in integrin-mediated affinity for neurites is necessary to cause 
preferential orientation of growth along the laminin containing strand. It suggests that 
this finding can be applied in the design of peripheral nerve repair scaffolds to guide 
the growth of neurites in a longitudinal direction. Specifically, the designer can select 
appropriate concentrations of material with high axon affinity for the guidance part of 
a scaffold, and low axon affinity materials for other parts. Further experiments using 
3D scaffolds in vitro and in vivo will be required to evaluate this prospective 
technique. 
Axon guidance requires that a coordinated presentation of multiple permissive 
factors is incorporated into tissue engineering scaffold design to promote axon growth. 
2D micropatterns, as model systems, have numerous potential applications in nerve 
tissue engineering [108]. Over the past decade, 2D patterns have been created by 
photolithography [240, 241] or by soft lithography [242] techniques for the study of 
axon guidance. DBRP, however, has many unique advantages for axon guidance 
applications. Compared with lithography methods, DBRP can easily create 2D 
micropatterns with different chemical features in different areas, and the geometric 
features of these micropatterns can be easily and well controlled. The 2D 
micropatterns fabricated by DBRP may also easily be used to develop 3D nerve 
conduit scaffolds with controllable microstructures. The inner layer strands of the 3D 
nerve conduit scaffolds could be fabricated using chitosan blended with laminin (or 
other growth-promoting proteins), while the rest of the strands of the scaffolds could 
be fabricated using pure chitosan. According to the results from the 2D micropattern 
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experiments, axons would preferentially grow along the laminin containing pathway 
(the inner layer strands) in such scaffolds. Meanwhile, the strand structure can also 
affect the orientation of growth of axons because of the curvature influences of the 
strand [111]. Ultimately, the DBRP technique has the potential to automate the design 
and fabrication of patient-specific scaffolds [92] based on the geometric requirements 
of each case of nerve injury.  
 
3.5. Conclusions 
Neurite growth on substrates of chitosan blended with laminin was investigated in 
cultures of adult DRG neurons. The results show that uniform ChLN6 substrates 
significantly improved neurite growth compared to ChLN0 or ChLN3 in neuron 
cultures. The DBRP technique was used to create 2D micropatterns with different 
biomaterials in different strands for the study of axon guidance. The micropatterns 
were designed to impart directionality to the growth of neurites in vitro. Quantitative 
analysis of growth vectors showed that DRG neurites preferred to grow along the 
direction of the ChLN6 strands compared with the ChLN0 strands. These results 
suggest that orientation of neurite growth can be achieved in an artificially patterned 
substrate by creating selective high-affinity pathways. 
DBRP is a promising technique for fabricating 2D micropatterns and building more 
complex 3D tissue engineering scaffolds with defined macro- and microstructures 
[243], with the capacity to precisely position bioactive molecules that may support 
and direct improved functional outcomes when tissue scaffolds are designed and 
utilized to assist in the regenerative repair of injured nerves.  
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CHAPTER 4 
DEVELOPMENT AND CHARACTERIZATION OF NOVEL HYBRID 
POLY(L-LACTIDE)/CHITOSAN SCAFFOLDS* 
 
*This chapter has been published as "Zhu N., Li M.G., Cooper D., Chen X.B. (2011) 
Development of novel hybrid poly (L-lactide)/chitosan scaffolds using the rapid 
freeze prototyping technique. Biofabrication. 3(3):034105". According to the 
Copyright Agreement, “the authors retain the right to include the journal article, in 
full or in part, in a thesis or dissertation”. 
 
4.1 Introduction 
  Made from biomaterial(s), tissue scaffolds are used to facilitate cell growth and 
transport of nutrients and wastes while degrading gradually themselves. As such, 
scaffolds have been shown critical to various tissue engineering applications. Ideally, 
scaffolds must [16, 244, 245]: (1) be easily fabricated into 3-dimensional (3D) 
structures with different shapes and sizes, (2) possess interconnected pores with 
appropriate scale for cell migration, new tissue integration, and vascularization, (3) 
have appropriate mechanical properties to matching those at the site of implantation 
and handling, (4) be made with controllable biodegradation properties, and (5) exhibit 
appropriate biochemical properties for cell attachment, differentiation and 
proliferation. To meet these requirements, various techniques have been developed for 
the scaffold fabrication, including both conventional and rapid prototyping 
(RP)-based techniques. Conventional techniques, such as leaching, gas foaming, 
solvent casting, melt molding, and phase separation, have several limitations in 
fabrication process; they are incapable of controlling pore geometry, spatial 
distribution of pores, and construction of internal channels within the scaffolds [92]. 
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In contrast, RP-based techniques, in which a 3D scaffold is manufactured by laying 
down multiple, formed layers in succession based on the use of computer-aided 
design information [246], has been shown be promising for the development of 
scaffolds. 
  Dispensing-based rapid prototyping (DBRP) technique is one of the RP-based 
techniques and has advantages over others in its ability of providing more accurate 
control on scaffold microstructure. During DBRP process, biomaterials in a fluid form 
are delivered to build scaffolds in a controllable manner [216]. Specifically, 
biomaterials are continuously extruded from a fine needle, forming strands to build 
2-dimensional (2D) or 3-dimensional (3D) micropatterns of scaffolds [216, 219]. The 
DBRP technique has been widely applied in tissue scaffold fabrication [177, 247-249]. 
With the need to develop advanced tissue scaffolds, the DBRP technique has been 
challenged by the facts that (1) the diameter of strands cannot be too small (typically 
greater than 100 μm) [247, 250], (2) high temperatures are present in dispensing 
melted polymers for the scaffold fabrication, which limits the incorporation of 
bioactive molecules in the scaffolds, and (3) the mechanical properties of polymer 
solution must be high enough to form 3D structure [216, 246], meanwhile without 
causing the difficulty in dispensing. To overcome these challenges, rapid freeze 
prototyping (RFP) technique has shown to be promising [251, 252], in which the 
polymer solution is dispensed on substrates with a controllable temperature, where the 
strands formed are frozen and lyophilized to remove the solvent. Compared to DBRP 
fabrication techniques, RFP technique has the advantage of fabricating tissue 
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scaffolds with, simultaneously, both sub-millimeter and micrometer levels of pores. 
Also, under low fabrication temperature, RFP technique can preserve and maintain the 
bioactivities of biomolecules encapsulated in the scaffolds. 
  This study reports the use of the RFP technique in the development of a novel 
hybrid poly (L-lactide)/chitosan scaffold for potential applications in tissue 
engineering. Poly (L-lactide) (PLLA) is a biodegradable polymer which has been 
widely used as a scaffold material in various tissue engineering applications [253-255]. 
PLLA exhibits strong mechanical properties and can be easily processed into 3D 
structure with complex shapes. Chitosan has also been widely applied in biomedical 
applications [256-258], especially in drug delivery system [259, 260]. Its cationic 
nature to be pH-dependent can greatly facilitate the retention or accumulation of 
bioactive molecules with a controllable manner [57]. Inspired by these previous 
studies, a study on the fabrication of PLLA/chitosan scaffolds was carried out, in 
which microspheres were made from chitosan or its mixture with bioactive molecules 
(as an example, bovine serum albumin (BSA) were examined in this study) and then 
added to the PLLA solution for scaffold fabrication by means of the RFP technique. 
The so-fabricated scaffolds are expected to have enhanced porous structure (including 
both sub-millimeter and micrometer levels of pores) and mechanical properties, as 
well as to provide a better means to control over the release of bioactive molecules via 
the use of microspheres than direct addition of them into the PLLA scaffolds.  
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4.2 Materials and Methods 
  Poly(L-lactide) (PLLA, MW: 105, product No.: B6002-2) was purchased from 
DURECT Corporation (United States). Bovine serum albumin (BSA) was purchased 
from BIO BASIC INC. (Canada). Chitosan (28191), tripolyphosphate (TPP) (72061), 
Span 80 (S6760), and paraffin oil (18512) were purchased from Sigma-Aldrich 
Canada. Acetic acid was diluted at 2% (wt/vol) concentration in distilled water as the 
stock solution. 
 
4.2.1 Fabrication processes 
(1) Chitosan microspheres (CMs) 
  In the preparation of non-loaded CMs or the CMs without the presence of BSA, 
chitosan was dissolved in 2% (wt/vol) acetic acid solution (10 ml). The chitosan 
solution was used as a water phase, while 50 ml liquid paraffin containing 1% (vol/vol) 
Span 80 emulsifier as an oil phase. The water phase was dispersed into the oil phase 
by using a magnetic stirrer to form water-in-oil (W/O) emulsion for 30 min with the 
stirring rate at a speed of 1200 rpm. Thereafter, TPP solution in water (2 ml) with the 
concentration of 2.5% (wt/vol) was slowly dropped into the W/O emulsion to solidify 
the chitosan droplets. The crosslinking reaction was allowed to proceed for a time 
period of 4 hours. The chitosan microspheres were separated by centrifugation, 
washed two times with isopropyl alcohol, two times with ethanol, one time with water 
under centrifugation of 3000 rpm and eventually the microspheres were lyophilized. 
  In the preparation of BSA-loaded CMs, chitosan was dissolved in 2.2% (wt/vol) 
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acetic acid solution and the chitosan solution (9 ml) was then mixed with a 1 ml of 
protein solution containing BSA at protein to polymer ratio of 1:50. The BSA loading 
microspheres were generated by employing the process similar to the one described 
above, but adding TPP solution (2 ml) with various concentrations (0.5%, 1.25%, and 
2.5% wt/vol) to the chitosan solution mixed with BSA. 
 
(2) Fabrication of solid-strand (SS) scaffolds by using DBRP technique 
  20% (wt/vol) PLLA was dissolved into 1,4-dioxane, and then mixed with 40% 
(wt/vol) CMs. Once uniformly mixed the mixture was loaded into a syringe of 5 ml 
on a precision fluid dispensing system (C0720M, Asymtek) for scaffold fabrication 
[261, 262]. The mixture was then extruded from a needle with a diameter of 240 μm 
onto glass coverslips layer by layer to form 3D structure scaffolds. The scaffolds 
became solid once the solvent volatilized. The fabrication process was performed at 
room temperature and the micropattern of the scaffolds was controlled by the system 
programming.  
 
(3) Fabrication of porous-strand (PS) scaffolds by using RFP technique 
  20% (wt/vol) PLLA was dissolved into 1,4-dioxane, and then mixed with 5% 
(wt/vol) non-loaded CMs. The fabrication process used to fabricate the PS scaffold by 
RFP is similar to the one by DBRP, except the temperature of the glass coverslips was 
controlled under -70 °C using dry ice; the polymer solution can be frozen after it was 
extruded on the coverslips. The 3D structure of the scaffolds can be preserved. The 
66 
 
frozen scaffolds were lyophilized to remove the solvent.  
 
4.2.2 Characterization of chitosan microspheres and scaffolds 
(1) Scanning electron microscopy (SEM) 
  The morphological features of the SS and PS scaffolds and CMs were investigated 
by means of scanning electron microscopy (SEM, EVO60, ZEISS). The samples were 
coated with gold using a Denton VACUUM DESK IV coater and the SEM images 
were captured with an accelerator voltage of 20 kV. 
 
(2) Microsphere size measurement 
  The mean values of the CM diameters after drying were measured by laser 
diffractometry. Freeze-dried CMs were re-dispersed in distilled water and sized by 
laser diffractometry using a Mastersizer (Malvern Co., UK).  
 
(3) Micro-computed tomography (μCT) 
  The architecture of the SS and PS scaffolds were analyzed by using a desktop μCT 
scanner (1172; SkyScan, Belgium) with a pixel size resolution of 3.46 μm. The x-ray 
source was set at a voltage of 40 kVp and beam current at 250 μA; the integration 
time used to acquire a single projection was 400 ms. Isotropic slice data were obtained 
by the system and reconstructed into 2D XY slice images. Approximately 1000 
projections per sample were compiled over a rotation range of 180° with a rotation 
step of 0.20°. Data sets were reconstructed using standardized cone-beam 
reconstruction software (NRecon v.1.4.3, SkyScan). The image data was used for 
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morphometric analysis (CT-Analyser v.1.10.10, SkyScan) on the scaffolds and to 
build 3D virtual models (CT-Volume v.2.1, SkyScan). The morphometric analysis 
included porosity, scaffolds interconnectivity, surface/volume ratio, and respective 
pore size and wall thickness distribution. 
 
(4) Fourier transform infrared spectroscopy (FTIR) 
The infrared spectra of the PLLA and PLLA/CMs PS scaffolds were measured with 
an FTIR (FT-IR 4100, JASCO) spectrophotometer. Each spectrum was acquired in 
attenuated total reflection (ATR) by accumulation of 32 scans with a resolution of 4 
cm-1 in the spectral range of 4000 - 400 cm-1. 
 
4.2.3 Tests of mechanical properties 
    To study the mechanical properties of the PLLA/CMs scaffolds, the compressive 
mechanical properties of the lyophilized scaffolds were tested with an ElectroForce 
5010 BioDynamic test instrument (BOSE Corporation - EletroForce System Group, 
United States). The cylindrical specimens were prepared with a diameter of 8mm and 
a height of 10 mm. Crosshead speed of 0.5 mm/min was used in the mechanical tests 
and the compression modulus was determined from the linear part of the stress versus 
strain curve. Three specimens were tested for each sample and their average values 
were used for data analysis. 
  To study the effect of cryogenic temperature used in the RFP fabrication process on 
the scaffold mechanical properties, the PLLA scaffolds lyophilized at -80, -40, -20, 
and 0°C, respectively were examined in the test of mechanical properties. Also, to 
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study the effect of different ratios of PLLA to CMs on the scaffold mechanical 
properties, the lyophilized PLLA/CMs scaffolds were used in the mechanical tests. 
Specifically, 20% (wt/vol) PLLA was dissolved into 1,4-dioxane, and then mixed with 
the non-loaded CMs at the ratio of CMs to PLLA being: 0%, 10%, and 25% (wt/wt), 
respectively. 
 
4.2.4 BSA release in vitro 
(1) BSA release from chitosan microspheres 
  The in vitro BSA release profiles of CMs were examined. Specifically, 10 mg of 
BSA-loaded CMs were re-suspended in phosphate buffered saline (PBS) (1 ml, pH 
7.4) in each centrifuge tube, then were placed in a thermostatic shaker (37 °C, 150 
rpm). At intervals of 2, 10, 24, 48, 72, 96, 120, 144, and 169 hours, samples were 
taken out of the thermostatic shaker and centrifuged at a speed of 8000 rpm for 5 min; 
0.5 ml of the supernatants from each tube were then carefully transferred to a quartz 
cuvette for the measurement of the BSA concentration. Each sample tube, then, was 
added with equal volume (0.5 ml) of fresh PBS to top up to the original volume. The 
BSA concentration of the supernatant was analyzed by using the UV 
spectrophotometry (Ultrospec III, Pharmacia, United Kingdom) at 280 nm using 
supernatant of non-loaded CMs as basic correction. For each condition, at least three 
samples were used. 
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(2) BSA release from PLLA/chitosan microspheres 
  The lyophilized PLLA scaffolds with BSA-loaded CMs (PLLA/CMs-BSA) were 
used for the study of BSA release. Specifically, 20% (wt/vol) PLLA was dissolved 
into 1,4-dioxane, and then mixed with the BSA-loaded CMs at the ratio of CMs to 
PLLA being 10% (wt/wt); the BSA-loaded CMs were crosslinked by adding 2.5% 
wt/vol TPP solution as described in section 4.2.1(1). The in vitro BSA release profiles 
of PLLA/CMs-BSA scaffolds were then examined. Specifically, 100 mg of the 
PLLA/CMs-BSA scaffolds were dipped in PBS (2.5 ml, pH 7.4) and kept in a 
thermostatic shaker (37 °C, 150 rpm). At intervals of 2, 4, 6, 8, 14, 20, 26, and 32 
days, 2.5 ml supernatant was collected from each sample for the measurement of the 
BSA concentration as described above and equal amount of fresh medium was added 
to each sample to top up to the original volume. For each condition, at least three 
samples were used. 
 
4.2.5 Statistical analysis 
An unpaired t-test was used to evaluate the results using Origin Pro 7.5 (OriginLab) 
software. Repeated-measure statistical analysis was employed to analyze the data for 
each of the character parameters. In all evaluations, p < 0.05 was considered to be 
statistically significant. 
 
4.3. Results and discussion 
4.3.1 Scaffold fabrication 
The CMs were fabricated by using water-in-oil (W/O) emulsification method 
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(Figure 4.1.a), and the mean values of the CM diameter was determined as 9.51 μm 
by using laser diffractometry. Figure 4.1.b shows the SEM image of the non-loaded 
CMs.  
 
Figure 4.1. Fabrication of chitosan microspheres (CMs); (a) schematic of 
emulsification method for the CMs fabrication and (b) SEM image for the non-loaded 
CMs. 23 
 
After adding the CMs into PLLA solution, the PS scaffolds were fabricated by 
using RFP technique shown in Figure 4.2. Compared with DBRP fabrication process, 
the RFP process needs to control the substrate temperature at low levels, so that the 
polymer strands become solid after the freezing process rather than the use of solvent 
volatilized process. Consequently, the diameter of the strands in the PS scaffolds 
(about 250 μm) is bigger than that in the SS scaffolds (about 200 μm) by using the 
identical size of the needle (Figure 4.3.a and c). Figure 4.3.b and d show the 
cross-section views of the SS scaffold strand and the PS scaffold strand, respectively. 
The strands of the PS scaffolds shows interconnected porous structure in a micrometer 
level, which is , however, hardly observed in the SS scaffold strands. 
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Figure 4.2. Fabrication of the solid-strand (SS) and porous-strand (PS) scaffolds; (a) 
schematic of the rapid prototyping technique for fabricating a SS scaffold; (b) camera 
image of a SS scaffold; (c) schematic of the rapid freeze prototyping technique for  
fabricating a PS scaffold; and (d) camera image of a PS scaffold.24 
 
  When using the DBRP technique for the PLLA/CMs scaffold fabrication, it was 
found that the concentration of the particles (CMs) in the polymer solution needed up 
to 40% in order to enhance the mechanical properties for the formation of 3D 
structure. It reflects that the polymer solution must be prepared with the yield stress 
high enough to build scaffold with 3D structure [216]. All of these suggest the 
addition of the particles into the polymer solution is essentially needed in the 
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fabrication process by means of the DBRP technique. In contrast, the RFP technique 
can eliminate the addition of the particles due to the use of the freezing process and as 
such, it is a process independent of the particle concentration to fabricate 3D 
scaffolds.  
 
Figure 4.3. SEM images of the solid-strand (SS) and porous-strand (PS) scaffolds; (a) 
top view of the SS scaffold; (b) cross-section view of the SS scaffold and the arrows 
show the CMs in the PLLA strand; (c) top view of the PS scaffold strand; and (d) 
cross-section view of the PS scaffold strand.25 
 
  It is well known that tissue scaffolds should be able to carry and release bioactive 
molecules, such as growth factors, in order to support and improve the attachment, 
proliferation, and differentiation of cells. Thus, maintaining the bioactivities of such 
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molecules during fabrication process may be needed. The DBRP process is carried out 
at high temperature or room temperature, which may cause the loss of molecular 
bioactivities. In contrast, the RFP process is performed at low temperature 
environment, which is beneficial for preserving the bioactivities of molecules in the 
scaffold fabrication. 
 
4.3.2 Analysis on the scaffold porous structure 
  Using μCT technique, the 3D microstructure of the PS and SS scaffolds were 
reconstructed, as shown in Figure 4.4. a and b. The porous structure features of the 
scaffolds were quantified based on the μCT image data. Table 4.1 shows the pore 
parameters of the PS and SS scaffolds. Both types of scaffolds a show highly 
interconnected structure, while the PS scaffolds have higher porosity and 
surface/volume ratio than the SS scaffolds. Figure 4.4.c shows the pore size 
distribution of the different scaffolds. It is seen that there are not only the macro size 
pores (150-400μm) but micro size pores (5-50 μm) in the PS scaffolds, while the main 
pore size ranges of the SS scaffolds and lyophilized scaffolds are only from 200 μm to 
400 μm and from 50 to 100 μm, respectively. Figure 4.4.d shows wall thickness of the 
PS and SS scaffolds, indicating that the wall thickness ranges for SS and PS scaffold 
are from 100 to 150 μm and from 20 to 30μm, respectively. During DBRP, the SS 
scaffolds solidify by means of the solvent volatilization; the wall thickness of the SS 
scaffold mainly depends on the diameter of the scaffold strand and/or the diameter of 
dispenser needle. Compared to the SS scaffolds, the PS scaffolds have much thinner 
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wall thickness. The PS scaffold strands have porous microstructure due to the 
lyophilization process; the wall thickness of the PS scaffolds reflects the 
microstructure inside the individual strands of the PS scaffolds. The results indicate 
that with the RFP technique, the PS scaffolds can be fabricated with high porosity, 
enhanced pore size distribution, and thinner wall thickness.  
   Previous research has shown that the growth of large organized cell communities 
requires optimized porous structure of the scaffolds [263]. This suggests that wide 
pore size distributions of the PS scaffolds may maximize cell utilization and permit 
spatially uniform tissue regeneration. The surface/volume ratio of the PS scaffolds is 
higher than that of the SS scaffolds. After the bioactive molecules are encapsulated 
into the scaffolds, high surface/volume ratio can result in the high efficiency of the 
biomolecules release from the scaffolds in vivo. Considered the effect of wall 
thickness of the scaffolds on scaffold degradation, the thinner the wall thickness of 
scaffold, the better controlled the degradation of scaffold can be. The surface of 
scaffolds exposed in biological environment may have different degradation rate from 
the unexposed parts of scaffolds in vivo because of the effect of biological 
environment on scaffold degradation. PLLA usually undergoes self-catalyzed 
degradation caused by its acidity production and acidity production of PLLA results 
in enhanced degradation. So the degradation rate at PLLA surface can be slower than 
that in the interior [264]. The PS scaffolds with the thin wall structure may facilitate 
uniform degradation of the scaffolds compared to the SS scaffolds. 
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Table 4.1. Porous structure comparison of the porous-strand (PS) scaffolds to the 
solid-strand (SS) scaffolds.1 
Scaffold 
Type 
Closed Porosity* 
(%) 
Total Porosity 
(%) 
Surface/Volume Ratio 
(μm-1) 
SS scaffolds 0.19 67.8 0.024 
PS scaffolds 0.0098 82.5 0.143 
* Closed porosity: the ratio of the closed pore volume to the total scaffold volume. 
 
 
Figure 4.4. Analysis on the porous structure of the porous-strand (PS) and solid-strand 
(SS) scaffolds using micro-tomography; (a) and (b) are the 3D reconstructed model of 
the SS and PS scaffolds, respectively, (c) the pore size distribution of the PS, SS, and 
lyophilized scaffolds, and (d) the wall thickness of the PS and SS scaffolds.26 
 
4.3.3 ATR-FTIR spectroscopy 
  In Figure 4.5, compared to the FT-IR spectrum of PLLA, the spectrum of the 
obtained PLLA/chitosan presented new absorption peaks around 1540, and 1650 cm-1, 
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which were assigned to the N–H bending vibration of amide II band and the carbonyl 
stretching of amide I band of the CMs, respectively. After the CMs were mixed 
mechanically with PLLA (Figure 4.1b), the values of frequencies of these bands 
hardly change. But the new bands, arising from N–H bending, appears at 1520 and 
1558 cm-1, the reason of which might be that a little PLLA was bonded with the 
chitosan by their molecular force. So the CMs can reinforce the material to a little 
extent. 
 
 
Figure 4.5. FTIR spectra of: (a) non-loaded chitosan microspheres (CMs); (b) 
PLLA/CMs porous-strand (PS) scaffolds; and (c) PLLA scaffolds.27 
 
4.3.4 Mechanical properties 
  Tests on the scaffold mechanical properties were carried out to investigate the effect 
of cryogenic temperature and the ratio of CMs to PLLA on the mechanical properties 
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of the PS scaffolds during the RFP fabrication process. Figure 4.6.a shows the 
compression modulus of PLLA scaffolds fabricated under different cryogenic 
temperatures (-80, -40, -20, and 0°C). The results showed that compression modulus 
of the scaffolds increased with the decrease of the cryogenic temperatures. After 
mixing CMs into PLLA solution, the result shown in Figure 4.6.b indicated that the 
compression modulus of the scaffolds increased with the increase of the ratios of CMs 
to PLLA. 
  The mechanical properties of tissue scaffolds are of great importance in tissue 
engineering applications due to the necessity of structural stability to withstand stress 
incurred during the implantation of the scaffolds in vivo. The mechanical properties 
can also significantly influence the specific biological functions of cells within the 
engineered tissue [265, 266]. This study demonstrates that the mechanical properties 
of the PS scaffolds can be controlled by adjusting the cryogenic temperatures. Lower 
cryogenic temperature can speed up the heat transfer rate and affect the crystal growth, 
leading to the smaller mean pore size of the scaffolds [226]. As a result, the 
compression modulus of the scaffolds can be increased. In addition, as discussed 
previously the formation of 3D structure by means of the RFP technique, the PS 
scaffolds are independent of the ratios of CMs to PLLA. The dependency of 
mechanical properties on the ratio of CMs to PLLA allows for the selection of its 
value in a more wider range so as to achieve the desired mechanical properties for a 
particular tissue regenerative application. 
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Figure 4.6. Compression modulus of the two kinds of lyophilized scaffold samples; (a) 
PLLA scaffolds fabricated under different cryogenic temperatures: -80, -40, -20, and 
0°C, respectively and (b) PLLA/CMs scaffolds fabricated under the cryogenic 
temperature of 0°C with different ratios of CMs to PLLA, i.e., 0%, 10%, and 25% 
(wt/wt).28 
 
4.3.5 In vitro BSA release  
  In the investigation of the BSA release profile, the BSA-loaded CMs treated with 
different concentration TPP solutions (i.e., 0.5, 1.25, and 2.5% (wt/vol)) were 
incubated in PBS pH 7.4, 37 °C for one week. Figure 4.7. shows the BSA release 
kinetics from the CMs. It is seen that the release profile is different, depending on the 
TPP concentration. Particularly, the percentage of the BSA release in the first 24 h is 
73.6±0.8% for the 2.5% TPP crosslinked CMs, 89.6±4.3% for the 1.25% TPP, and 
94.2±2.4% for the 0.5% TPP. Compared to 1.25% and 0.5% TPP crosslinked CMs, 
the initial burst release of the 2.5% TPP was significantly different (p<0.01) in the 
first 24 h of release process. High initial burst release is problematic in most protein 
delivery applications because dose dumping is both inefficient and potentially harmful 
to the target tissue [267]. The results suggest that the higher TPP concentration causes 
higher crosslinking degree of CMs and delays protein diffusion across the phase 
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boundary to reduce the initial burst release. The crosslinking process of chitosan - 
TPP is predominantly ionic cross-linked [268]. TPP containing negative charges 
(P3O5–10 ions) interact with the –NH+3 amino groups of chitosan. During the BSA 
release process (pH=7.4), BSA surface shows negative charges, which will avoid the 
effect of TPP on BSA release. 
 
Figure 4.7. BSA release from chitosan microspheres in PBS pH 7.4, 37 °C. 
Chitosan/BSA microspheres (50:1 wt/wt) were prepared by emulsification method 
crosslinked by tripolyphosphate (TPP) solution with concentrations of 0.5, 1.25, and 
2.5% (wt/vol), respectively. Values represent means and standard deviations (n=3).29 
 
  In the investigation of BSA release from PLLA/CMs-BSA scaffolds, the BSA 
loaded CMs crosslinked by 2.5% TPP were used to mix into PLLA scaffolds. The 
same content of BSA-loaded CMs was used for both BSA release from free floating 
CMs and PLLA/CMs scaffolds. From the BSA release profile shown in Figure 4.8, 
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the complete release of BSA from the PLLA/CMs-BSA scaffolds took 34 days and 
about 49.0±2.1% BSA was released in the first 4 days. In contrast, BSA release from 
free floating CMs in Figure 4.7. is 80.6±1.0% in the first 4 days, which is significantly 
higher (p < 0.01) than that from the PLLA/CMs-BSA scaffolds. After embedding 
CMs into PLLA scaffolds, the BSA release period can be prolonged because the BSA 
release from PLLA occurred by a combined diffusion-degradation mechanism. 
  In tissue engineering, the bioactive molecules need to be gradually released from 
scaffolds during the period of new tissue regeneration. The use of CMs to carry the 
bioactive molecules can better encapsulate, control, and manipulate biomolecules 
from PLLA PS scaffolds compared to the scaffolds directly encapsulating the 
bioactive molecules. The crosslinking degree can affect chitosan bioadhesive 
properties and release of the biomolecules [269]. The BSA initial burst release, 
therefore, can be controlled by the treatment with different crosslinking degree. 
Meanwhile, the PLLA/CMs system can prolong protein release process. The 
long-term protein release is beneficial to promote and maintain functional recovery in 
tissue engineering applications, such as nerve [102] and bone [270] tissue engineering. 
Furthermore, the combination of RFP technique with the use of CMs provides an 
effective way of controlling the biomolecule distribution and the total biomolecule 
encapsulation content in the scaffolds. The different biomolecule-loaded CMs can be 
placed into the specific designed strands of the scaffolds using RFP system with 
muti-nozzle dispensers [252]. The total biomolecule encapsulation content in the 
PLLA/CMs PS scaffolds can be adjusted by means of choosing a percentage of 
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BSA-loaded CMs in the RFP dispenser/syringe and independent of biomolecule 
encapsulation efficiency of CMs. The RFP/CMs system shows the potential to 
improve the control of the biomolecule release in the scaffolds. 
 
 
Figure 4.8. BSA release from the PLLA/CMs-BSA scaffolds in PBS pH 7.4, 37 °C for 
32 days. Values represent means and standard deviations (n=3).30 
 
4.4. Conclusions 
  This paper presents the development of a novel three-dimensional scaffold made 
from the mixture of CMs and poly (L-lactide) by means of the RFP technique. 
Compared to the DBRP technique, the RFP technique is able to achieve improved 
porous structure of scaffolds, which includes higher porosity, enhanced pore size 
distribution, and thinner wall thickness. The improved porous structure would 
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facilitate cell and tissue migration and vascularization. In the novel PLLA/chitosan 
scaffolds, the CMs are used to encapsulate and release bioactive molecules. The FTIR 
results show the CMs were mechanically mixed into the PLLA scaffolds. The 
experimental results of the BSA release demonstrate that the use of the CMs is an 
effective way to administrate the BSA release and that its rate can be controlled by 
adjusting the crosslinking degree of the CMs; the BSA release period can be 
prolonged after the CMs are embedded into PLLA scaffolds. The experimental results 
also show the addition of the CMs to the PLLA scaffolds can improve the mechanical 
properties of the scaffolds, depending on cryogenic temperature used in the scaffold 
fabrication process. The present study demonstrates that the novel PLLA/chitosan 
scaffolds fabricated by using the RFP technique have enhanced porous structure and 
mechanical properties. The RFP technique shows the potential to preserve the 
bioactivities of the biomolecules in the scaffolds.  
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CHAPTER 5 
A STUDY ON THE IN VITRO DEGRADATION OF 
POLY(L-LACTIDE)/CHITOSAN-MICROSPHERES SCAFFOLDS 
 
5.1 Introduction 
  Scaffold degradation is one of the key considerations in the design and fabrication 
of tissue engineered scaffolds. In tissue engineering, biodegradable scaffolds must be 
able to maintain their physical and chemical characteristics, as well as mechanical 
properties, in order to support new tissue growth until tissue is regenerated at an 
injured site. Ideally, the degradation rate of scaffolds should match the rate of new 
tissue formation, which allows a smooth transition of load transfer from scaffolds to 
tissue [271]. However, the challenge of scaffold design is to control and adjust 
scaffold behaviors to meet the requirements of different tissue engineering 
applications. 
  Depending on the mode of degradation, polymeric biodegradable biomaterials can 
be classified into hydrolytic degradable polymers and enzymatic degradable polymers 
[272]. Most natural polymers undergo enzymatic degradation. The degradation rate of 
enzymatic degradable polymers varies significantly with the site of implantation and 
depends on the availability and concentration of the enzymes. On the other hand, 
degradation of synthetic polymers generally occur due to cleavage of hydrolytic 
sensitive linkages in the polymer. Synthetic polymers have more predictable 
properties and batch-to-batch uniformity and their property profiles can be tailored for 
specific tissue engineering applications. Therefore, they are devoid of many of the 
disadvantages of natural polymers [66].  
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  Poly (L-lactide) (PLLA) is a type of nontoxic, biodegradable, synthetic polymer, 
which is widely used as a scaffold material in tissue engineering, such as nerve [30], 
cartilage [273], and bone [274] tissue regeneration. PLLA undergoes hydrolysis of the 
ester groups to form the harmless product L-lactic acid. Degradation properties are 
dependent on several factors, such as molecular weight [275], crystallinity [276], and 
sample size and shape [277]. These factors can be used to predict and control the 
degradation behaviors of PLLA scaffolds. However, concerns exist regarding the use 
of  PLLA as the only biomaterial in building tissue scaffolds. PLLA has obvious 
weaknesses during in vivo degradation, i.e., biodegrading too quickly and creation of 
acidic degradation products [278]. 
  Chitosan is a natural polymer derived from chitin, which is widely found in shells 
of crustaceans such as crabs and shrimps. It has been shown to have excellent 
biocompatibility when applied to tissue engineering [53, 279]. Combination of 
chitosan with synthetic PLLA might overcome some of the drawbacks of PLLA alone 
[280]. Chitosan, as an alkalescent polymer, can neutralize the acidity generated, 
thereby eliminating the inflammations which prolongs the exiting of the material from 
the body. Recently, poly (L-lactide)/chitosan microspheres (PLLA/CMs) scaffolds 
were successfully developed in the authors' laboratory [281]. CMs added to the PLLA 
scaffolds may not only improve the biocompatibility and mechanical properties of the 
scaffolds but also enable manipulate bioactive molecule release from the scaffolds 
[281]. However, the degradation properties of the composite material scaffolds are 
still not well understood. Therefore, in the present study, the effect of chitosan 
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microspheres on PLLA degradation was investigated using weight loss, differential 
scanning calorimetry (DSC), and Raman spectroscopy. In particular, micro-computed 
tomography (μCT) was used to monitor and quantify the morphological changes 
during scaffold degradation. The results were also compared to the degradation 
behaviors of pure PLLA scaffolds. 
 
5.2 Materials and Methods 
5.2.1 Materials   
Poly(L-lactide) (PLLA, MW: 105 g﹒mol-1, product No.: B6002-2) was purchased 
from DURECT Corporation (United States). Chitosan (28191), tripolyphosphate (TPP) 
(72061), Span 80 (S6760), and  paraffin oil (18512) were purchased from 
Sigma-Aldrich Canada. Acetic acid was diluted with distilled water at a concentration 
of 2% (wt/vol) for the stock solution. 
 
5.2.2 Scaffold fabrication 
(1) Chitosan microspheres (CMs) 
  To prepare the the CMs, chitosan was dissolved in the 2% (wt/vol) acetic acid 
solution to obtain 2% (wt/vol) chitosan solution. 10 mL chitosan solution was used as 
a water phase, while 50 ml liquid paraffin containing 1% (vol/vol) Span 80 emulsifier 
was the the oil phase. To form water-in-oil (W/O) emulsion, the water phase was 
dispersed into the oil phase using a magnetic stirrer with a stirring rate of 1200 rpm 
for 30 min. To solidify the chitosan droplets, a TPP solution in water (2 ml) with a 
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concentration of 2.5% (wt/vol) was slowly dropped into the W/O emulsion. The 
crosslinking reaction was allowed to proceed for 4 hours. The CMs were separated 
centrifugally, washed twice with isopropyl alcohol, twice with ethanol, and once with 
water using a centrifuge at 3000 rpm. Finally, the microspheres were lyophilized. 
 
(2) Preparation of PLLA/CMs scaffold 
  The composite porous scaffolds were fabricated using a lyophilization technique. 
Briefly, a known amount of PLLA was dissolved into 1,4-dioxane to obtain 6% 
(wt/vol) PLLA solution. This was mixed with the CMs (particle size ~10 μm) at a 
CMs to PLLA ratio of 25%. The resulting solution was poured into cylindrical molds 
and frozen below -20°C. The frozen scaffolds were lyophilized to remove the solvent. 
PLLA scaffolds were fabricated using the same without addition of CMs. 
 
5.2.3 Scaffold degradation in vitro 
  The cylindrical shape PLLA/CMs scaffolds weighing approximately 70 mg were 
placed in vials filled with 5 mL of phosphate buffered saline (PBS) (pH 7.4). These 
are incubated in vitro using a shaking air bath at 37°C and 100 rpm for 8 weeks. The 
PBS solution was replaced once a week. At specific time intervals (2, 4, 6, and 8 
weeks), parts of the samples were removed from the buffer and washed thoroughly 
with distilled water, followed by drying at room temperature under reduced pressure 
for at least 24 hours. The degraded scaffolds were kept in a desiccator until further use. 
PLLA scaffolds were treated similarly.  
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5.2.4 Characterization  
(1) Micro-computed tomography (μCT) 
  During degradation, the same scaffold from each group (PLLA/CMs and PLLA) 
was taken out of the PBS solution at time intervals (0, 6, and 8 weeks) and scanned 
using a desktop μCT scanner (1172; SkyScan, Belgium) with a pixel size resolution of 
3.46 μm. The scaffolds were dried at room temperature under reduced pressure for at 
least 24 hours before μCT scanning and immersed into the PBS solution again after 
the scanning.  
  For microstructure analysis of the degraded scaffolds, the x-ray source was set to a 
voltage of 40 kVp and beam current of 250 μA. The integration time used to acquire a 
single projection was 400 ms. Isotropic slice data were obtained by the system and 
reconstructed into two-dimensional XY slice images. Approximately 1000 projections 
per sample were compiled over a rotation range of 180° with a rotation step of 0.20°. 
Data sets were reconstructed using standardized cone-beam reconstruction software 
(NRecon v.1.4.3, SkyScan). The image data was used for morphometric analysis 
(CT-Analyser v.1.10.10, SkyScan) of the scaffolds. The pore size thickness 
distribution of the degraded scaffolds was obtained from the morphometric analysis. 
 
(2) Weight loss 
  The percentage weight loss of degraded scaffolds was calculated from the weights 
of the dried scaffolds before and after hydrolysis according to:  
Wloss (%) = (m0-md)/m0×100%                                      (5.1) 
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where Wloss(%) is the percentage weight loss of the degraded scaffold; m0 is the 
weight of the dried scaffold before degradation, and md is the weight of the dried 
scaffold after degradation. 
  Three specimens were tested for each sample and their average values were used 
for data analysis. 
 
(3) Raman spectroscopy 
  Raman spectra of the degraded scaffolds were obtained and measured with a inVia 
Raman microscope (RENISHAW Inc., UK). A laser with a 785 nm line was used as 
the excitation source for the Raman spectra. The exposure time and accumulation for 
obtaining the Raman spectra were 10 s and 16 times, respectively. The laser power at 
the sample surface was 100 mW. A curve fit of the spectra was performed using 
WiRE 3.2 software with a mixture of Gaussian and Lorentz functions. 
 
(4) Differential scanning calorimetry (DSC) 
  A Q2000 differential scanning calorimeter (TA instruments, U.S.A.) was used to 
obtain DSC thermograms of the degraded scaffolds. Samples with a mass of 
approximately 10 mg were first sealed in an aluminum pan. DSC measurements were 
then performed on samples which were heated from 10°C to 200°C at 10°C/min. Heat 
of Fusion is directly proportional to crystallinity (χ%) and it was calculated by: 
  χ%=△Hf/△H0                                                  (5. 2) 
where △Hf is the fusion enthalpy of the sample, and △H0 is the theoretical heat of 
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fusion for crystalline PLLA and it was taken as 135 J/g [282]. 
 
5.3 Results 
5.3.1 Scaffold microstructure analysis 
  The microstructural changes of both PLLA and PLLA/CMs scaffolds were 
monitored by μCT. During scaffold degradation in vitro, the scaffold microstructure 
analysis was based on a sample taken at different time points. After μCT scanning, a 
three dimensional scaffold model was reconstructed and the pore-structural features 
were quantified from the model. Figure 5.1a shows the pore size distribution of a 
PLLA scaffold at 0, 6, and 8 weeks. The peaks of the distribution curves move to the 
right for samples from 0 to 8 weeks. This means that a large percent of pores were 
distributed approximately 60 μm before the scaffold degraded, but this changed to  
approximately 90 μm after degradation for 8 weeks. The result demonstrates that the 
scaffold degradation led to changes of pore size inside the scaffolds due to the 
polymer hydrolysis. Figure 5.1b shows the pore size distribution of a PLLA/CMs 
scaffold at 0, 6, and 8 weeks. The distribution curves do not move significantly during 
the scaffold degradation, therefore, the pore size distribution of the scaffolds does not 
significantly change after the scaffold degradation. The results suggest that adding 
CMs to PLLA causes the degradation rate of the PLLA/CMs scaffolds to be slower 
than the PLLA scaffolds. 
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Figure 5.1. Micro-tomography quantitative analysis for pore size distribution of the 
PLLA (a) and PLLA/CMs (b) scaffolds at time point 0, 6, and 8 week during scaffold 
degradation in PBS for 8 weeks in vitro.31 
 
5.3.2 Weight loss 
  Figure 5.2 shows the mass changes of both PLLA and PLLA/CMs scaffolds, which 
were monitored during the degradation process. The mass loss of the PLLA scaffolds 
was approximately 7.6% after 8 weeks, which was higher than that of the PLLA/CMs 
scaffolds (approximately 5.9%). The weight loss curves indicate that the PLLA 
scaffolds degrade faster than PLLA/CMs scaffolds throughout the degradation 
process. 
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Figure 5.2. Weight loss of the PLLA (a) and PLLA/CMs (b) scaffolds during scaffold 
degradation in PBS for 8 weeks in vitro.32 
 
5.3.3 Spectroscopic characterization 
  Figure 5.3 shows the Raman spectra of a PLLA scaffold before degradation (a) and 
after degradation for 8 weeks (b) and of a PLLA/CMs scaffold before degradation (c) 
and after degradation for 8 weeks (d). The spectra of both PLLA and PLLA/CMs 
presented significant Raman peaks at 875 and 1452 cm-1. These peak positions are 
consistent with the PLLA spectrum reported in previous research [283]. The 857cm-1 
peak is attributed to the C-COO stretching modes in the chain, while the 1452 cm-1 
band is attributed to the CH3 symmetric bending. Previous studies on PLLA showed 
that the Raman I875/I1452 intensity ratio constitutes a spectroscopic marker of the 
polymeric chain length [284]. The 1452 band can be taken as internal standard. 
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During PLLA degradation, long PLLA molecular chains break into short ones, which 
leads to the decrease of the I875/I1452 intensity ratio [285]. The Raman I875/I1452 
intensity ratios of PLLA and PLLA/CMs are shown in Figure 5.4. The Raman 
I875/I1452 intensity ratios for both materials do not significantly change up to four 
weeks. After 8 weeks of degradation in PBS, Figure 5.4 suggests that the chain length 
of PLLA decreases more quickly than PLLA/CMs. 
 
Figure 5.3. Raman spectra of both PLLA and PLLA/CMs scaffolds during 
degradation in PBS for 8 weeks in vitro. (a) PLLA scaffolds degraded for 0 week, (b) 
PLLA scaffolds degraded for 8 weeks, (c) PLLA/CMs scaffolds degraded for 0 week, 
and (d) PLLA/CMs scaffolds degraded for 8 weeks.33 
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Figure 5.4. Raman I875/I1452 intensity ratios for PLLA and PLLA/CMs scaffolds during 
degradation in PBS for 8 weeks in vitro.34 
 
5.3.4 Differential scanning calorimetry (DSC)  
  DSC measurements were performed to further describe the degradation behaviour 
of PLLA/CMs scaffolds. In table 5.1, the crystallinity (χ%) of PLLA in both PLLA 
and PLLA/CMs scaffolds were calculated based on the enthalpy of melting (△H) of 
PLLA from DSC thermograms. The χ% of PLLA in the undegraded PLLA/CMs 
scaffolds is noticeably lower than that in the PLLA scaffolds. The result demonstrates 
that adding CMs into PLLA increases PLLA lattice disorder and/or decreases 
crystalline thickness during scaffold fabrication. During scaffold degradation, the χ% 
of PLLA in both PLLA and PLLA/CMs scaffolds gradually increased due to the 
factor that the crystalline residues formed as a result of selective hydrolysis and 
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removal of the chains in the amorphous state occurred first [286]. The changes of 
PLLA χ% in both scaffolds are plotted in Figure 5.5 as a function of hydrolysis time. 
The crystallinity of the PLLA in PLLA/CMs scaffolds increases slightly slower than 
that in PLLA scaffolds after 4 weeks of degradation. This suggests that the 
PLLA/CMs scaffolds degrade slower than PLLA scaffolds.  
 
Table 5.1. Thermodynamic characteristics of PLLA and PLLA/CMs after scaffold 
degradation in PBS in vitro for 0, 2, 4, 8 weeks.2 
Sample Time(weeks) △H(J/g) χ(%) 
PLLA 
0 46.12 34.2 
2 46.3 34.3 
4 48.36 35.8 
8 49.14 36.5 
PLLA/CMs 
0 33.18 24.6 
2 34.29 25.4 
4 35.89 26.6 
8 36.12 26.8 
 
 
Figure 5.5. Crystallinity (χ%) of PLLA in PLLA and PLLA/CMs scaffolds as a 
function of degradation time.35 
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5.4 Discussion 
  The structural features of a scaffold play an important role in new tissue 
regeneration. Engineered scaffolds fabricated from biodegradable polymers will 
experience internal and external structural changes during the whole scaffold 
degradation/tissue growth process. Monitoring structural changes of a scaffold during 
degradation is a challenge in tissue engineering due to the limitations of conventional 
invasive methods, such as scanning electron microscopy, light microscopy, mercury 
intrusion porosimetry, and the gas expansion method. μCT is a non-invasive and 
non-destructive method, which is able to quantify scaffold microstructural features 
without damaging the samples. In the study, a μCT was used to monitor PLLA and 
PLLA/CMs scaffold degradation behaviours. One sample from each group was used 
for microstructural analysis by μCT and the same sample was monitored at each time 
point during degradation. Using the same sample ensured that the results would be 
more comparable and reliable than results obtained from different samples at each 
time point. 
  The results from weight loss, Raman spectroscopy, and DSC analysis are consistent 
with the μCT results, which show that the PLLA/CMs scaffolds degrade more slowly 
than pure PLLA scaffolds. Chitosan added to PLLA causes a decrease of PLLA 
hydrolysis. As PLLA degrades, long chain molecules are degraded into short chain 
molecules and the small molecules in PLLA degradation products are acidic. 
Therefore, PLLA usually undergoes self-catalyzed degradation caused by its acidity 
production and this results in enhanced degradation [264]. The alkalescent 
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degradation products of chitosan can neutralize the acidity generated by PLLA 
degradation and thereby inhibit the hydrolysis of PLLA [278], which may slow the 
changes of the Raman I875/I1452 intensity ratio in PLLA/CMs during degradation.  
  The degradation rate of PLLA/CMs scaffolds should be controlled to match the 
new tissue regrowth according to different tissue injury processes. For example, it 
took approximately 3 months to bridge 10-mm sciatic nerve defects in rats [62], but 
over 6 months for the repair of 30-mm-long dog sciatic nerve defects [287]. In nerve 
tissue regeneration, one of the disadvantages of PLLA scaffold is its rapid degradation 
based on the hydrolysis of the polyester bond [288]. Adding chitosan microspheres 
into PLLA scaffolds can decrease the hydrolysis rate of PLLA. This factor combined 
with other factors, such as, polymer molecular weight, crystallinity, shape, and wall 
morphology, can be used to adjust and/or control the degradation behaviours of PLLA 
scaffolds in order to meet the requirements of specific tissue engineering applications.  
 
5.5 Conclusions 
  The results obtained from in vitro degradation experiments of PLLA/CMs scaffolds 
showed that there was a decrease in the degradation rate of the composite scaffolds in 
phosphate-buffer solution with pH 7.4 at 37°C after 8 weeks compared with pure 
PLLA scaffolds. The addition of CMs into PLLA slowed the hydrolysis of PLLA 
after 4 weeks degradation and also resulted in the decrease of PLLA crystallinity 
during scaffold fabrication. The biodegradation behavior of PLLA can be regulated 
and adjusted by adding CMs.   
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  The μCT technique employed in the present work is capable of monitoring 
microstructural changes of scaffolds during degradation. This new application allows 
a deeper insight towards understanding scaffold degradation behavior and possible 
visualization of new tissue growth as well. 
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CHAPTER 6 
X-RAY DIFFRACTION ENHANCED IMAGING AS A NOVEL METHOD TO 
THE VISUALIZATION OF PLLA/CHITOSAN SCAFFOLDS FOR SOFT TISSUE 
ENGINEERING APPLICATIONS* 
 
*This chapter has been accepted for publication as "Zhu N., Chapman D., Cooper D., 
Schreyer D.J., Chen X.B. (2011) X-ray diffraction enhanced imaging as a novel 
method to visualize low-density scaffolds in soft tissue engineering. Tissue 
Engineering Part C. 17(11): 1071-1080". According to the Copyright Agreement, 
"the authors retain the right to include the journal article, in full or in part, in a thesis 
or dissertation". 
 
6.1 Introduction 
  In tissue engineering, biomedical imaging techniques play an important role in the 
characterization of biomaterials, scaffolds, cells, and engineered tissue [289]. 
Conventional imaging techniques applied in tissue engineering include scanning 
electron microscopy (SEM), transmission electron microscopy (TEM), and confocal 
laser scanning microscopy (CLSM). SEM has become a standard visualisation method 
for morphology elucidation and is widely used to reveal scaffold microstructures [117, 
126] and cell-substrate interactions [135]. However, as a two-dimensional (2D) 
visualization tool the utility of SEM for quantitative analysis and characterization of 
three-dimensional (3D) structures is limited. TEM is another electron microscopy 
technique used to obtain images in nanometer scale. As such, it enables the 
observation of regenerative tissue at the cellular level [139, 140]. However, the 
disadvantages of TEM include the need for specially prepared thin samples that 
hardly convey the 3D arrangement of samples at the micrometer or larger level. 
CLSM enables to obtain high resolution optical images with depth selectivity. It has 
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gained popularity for 3D slides of fluorescent-stained tissue or biomaterial samples in 
various tissue engineering applications [118, 146, 147]. However, the penetration 
depth of CLSM is limited to about 300 μm. Progress in tissue engineering requires 
more detailed information on tissue physiology and the dynamics of scaffold structure 
(e.g., integration/degradation); thus, innovative imaging techniques are needed, 
including advancements from 2D to 3D image analysis and quantification, from label 
techniques to label-free techniques, and from invasive/destructive methods to 
non-invasive, non-destructive, and real-time methods [125].  
  X-ray micro-tomography (μCT) techniques, which are non-destructive and 
non-invasive, are becoming increasingly important for 3D visualization of scaffolds 
and engineered tissues in recent years. μCT can produce 3D image information to 
reveal the microstructure of scaffolds and regenerative tissues with specimen sizes 
from a few millimeters to 100 μm in size and provide nominal resolutions from 5 to 
100 μm [119]. Quantitative architectural parameters of scaffolds, such as porosity, 
pore size, and pore wall thicknesses, can be extracted from μCT tomographic images 
[178, 290]. The new tissue growth and neovascularisation in scaffolds can also be 
visualized through 3D models reconstructed from the μCT data [291, 292]. 
Furthermore, the non-invasive aspects allow this technique to be used to monitor new 
tissue regrowth in vivo in a time-lapsed fashion [181]. Although μCT techniques have 
been widely applied in bone tissue engineering, there have been few applications of 
μCT to soft tissue (e.g., nerve, vascular, and liver) engineering. The main obstacle is 
the low x-ray attenuation contrast of low density scaffolds and soft tissues. Another 
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issue is the high ionizing radiation dose absorbed by engineered tissue samples during 
μCT imaging which has potential effects on cellular activity during the repair process 
[293, 294]. 
  X-ray phase contrast imaging techniques differ from conventional attenuation 
contrast based x-ray imaging techniques because they instead rely on the refraction 
properties of object structure; they thus promise better contrast at lower doses [295]. 
Coupling synchrotron radiation (SR) based x-ray sources to phase contrast imaging 
techniques offers advantages such as better image quality, high photon flux, the 
possibility for monochromatization with a brilliance several orders of magnitude 
higher than those of a standard x-ray source, high spatial resolution (< 1 μm), and a 
better signal-to-noise ratio [120, 170]. In-line phase contrast imaging (in-line PCI) 
based on interference is one of the x-ray phase contrast imaging techniques [296] that 
has been successfully applied in the visualization studies in soft tissue engineering, 
including imaging of articular cartilage [202], sciatic nerves [201], and microvascular 
networks in bioceramic scaffolds [297]. In-line PCI is restricted to either thin objects 
or high x-ray imaging energies [298]. Diffraction enhanced imaging (DEI), another 
important x-ray phase contrast imaging technique, does not depend on interferometric 
techniques and works well with thick samples. Due to the use of a crystal analyzer 
with high angular resolution, DEI is sensitive to the boundary between tissues and/or 
biomaterials with different refractive indices [204, 212, 299]. It is possible to obtain 
scatter-free absorption contrast images or refraction images rather than a mixture of 
the two. DEI has been used in visualization of soft tissues, for example, in the 
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characterization of breast cancer [121, 300] and cochlea [301]. To date, little work has 
been reported in tissue engineering to take the aforementioned advantages of DEI to 
the visualization of soft engineered scaffolds and tissues. 
  This paper presents a study on the use of X-ray DEI to visualize low-density 
scaffolds in soft tissue engineering. Specifically, poly (L-lactide)/chitosan scaffolds 
embedded in rat muscle tissue were imaged using radiography, in-line PCI, and DEI 
techniques, respectively. The comparisons of image contrasts and other features based 
on these x-ray imaging techniques were carried out. All comparisons were based on 
images acquired of identical scaffold samples. To the best of our knowledge, this is 
the first report on the visualization of engineered scaffolds using a DEI technique. 
 
6.2 Materials and Methods 
  Poly(L-lactide) (PLLA, mw: 105, product No.: B6002-2) was purchased from 
DURECT Corporation (United States). Chitosan (28191), Span 80, and 
glutaraldehyde were purchased from Sigma-Aldrich Canada. Acetic acid was diluted 
at 2% (wt/vol) concentration in distilled water as the stock solution. 
 
6.2.1 PLLA/chitosan scaffold fabrication  
(1) Chitosan microspheres 
  Chitosan microspheres (CM) were prepared using an emulsion-ionic crosslinking 
method. Briefly, chitosan (200 mg) was dissolved in 2% (wt/vol) acetic acid solution 
(10 mL). Liquid paraffin (50 mL) containing 1% (vol/vol) Span 80 emulsifier was 
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used as an oil phase. The water phase was dispersed into the oil phase using a 
magnetic stirrer (1000 prm) for 30 min to form a water-in-oil (W/O) emulsion. Next, 
glutaraldehyde as a crosslinking agent was slowly dropped into the W/O emulsion to 
solidify the chitosan droplets. The crosslinking reaction was allowed to proceed for 2 
hours. Once separated by means of centrifugation, the chitosan microspheres were 
washed two times with isopropyl alcohol, two times with ethanol, four times with 
distilled water under centrifugation of 3000 rpm, and eventually lyophilized. 
 
(2) Grid pattern PLLA/chitosan scaffolds 
  Tissue engineered scaffolds were fabricated using a dispensing-based fabrication 
system [262]. Briefly, 20% (wt/vol) PLLA was dissolved into chloroform and then 
mixed with 40% (wt/vol) chitosan microspheres. After the chitosan microspheres were 
uniformly mixed into PLLA solution, the mixture obtained was then loaded into the 
dispenser for scaffold fabrication. Under pressurized air, the mixture was extruded 
onto a glass substrate layer by layer, forming scaffolds with a 3D grid-pattern 
structure. The scaffolds became solid once the chloroform volatilized. 
 
6.2.2 Sample preparation 
(1) Tissue sample preparation 
  A Sprague Dawley rat was deeply anesthetized and perfused transcardially with 
0.1M phosphate buffered saline (PBS), pH 7.4, followed by 4% paraformaldehyde in 
0.1M PBS. Muscle tissues were then removed from the rat for x-ray imaging and 
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histological experiments. Animals were cared for according to the protocols of the 
Committee on Animal Care of the University of Saskatchewan (Animal Use Protocol 
#20080046). 
 
(2) Scaffold sample preparation for x-ray imaging 
  PLLA/chitosan scaffolds were trimmed to a thickness of 0.5 mm. One of the 
scaffolds was selected and then sequentially put into different media for imaging. 
Specifically, the scaffold was 1) placed in air hereafter referred to as "A-scaffold", 
and directly exposed in x-rays for imaging; 2) embedded into rat muscle tissue with a 
total thickness of both scaffold and tissues of 5 mm ("M-scaffold"); then 3) removed 
from the rat tissue and immersed into water in containers with different inner 
thickness for imaging ("W-scaffold"), and the inner thickness of containers was 1, 4, 
and 5 cm, respectively.  
 
6.2.3 Laboratory x-ray imaging 
 The laboratory x-ray images of the samples were captured using a SkyScan 1172 
system (Skyscan, Kontich, Belgium) with an image pixel size of 3.5 μm. The x-ray 
source was set at an energy of 60 kVp. To enable comparison with the synchrotron 
x-ray images, experiments were performed only in projection mode with a single 
magnified image of the sample at the x-ray energy recorded. 
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6.2.4 Synchrotron radiation based (SR) x-ray imaging 
  SR x-ray imaging experiments were carried out on the BioMedical Imaging and 
Therapy (BMIT) beamline at the Canadian Light Source (CLS), Saskatoon, Canada. 
(1) SR-radiography and in-line phase contrast imaging (in-line PCI) 
  Figure 6.1 is a schematic of the SR-radiography and in-line PCI setups. The 
samples were exposed to the synchrotron generated x-rays at different stage positions 
(Sample to Detector distance (SD)) to obtain absorption contrast (SD=2 cm) and 
phase contrast (SD=72 cm) projection images. Three different x-ray photon energy 
energies (15, 20, and 25 KeV) were applied in the imaging processes.  
 
Figure 6.1. Systems for synchrotron radiation based (SR) (a) radiography and (b) 
in-line phase contrast imaging (in-line PCI). The difference between setups (a) and (b) 
is the Sample to Detector distance (SD), which influences the attenuation of 
absorption contrast or phase contrast. The SD was set at 2 cm (SR-radiography) and 
72 cm (in-line PCI) in (a) and (b), respectively.36 
 
(2) Diffraction enhanced imaging (DEI) 
  Figure 6.2 is a schematic of the DEI setup. The white synchrotron beam was 
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monochromatized by a Si (220) double-crystal monochromator. The crystal analyzer 
was arranged behind the samples and installed on an axis that can rotate in order to be 
tuned to any position of its rocking curve. The DEI images were recorded by means of 
a beam monitor AA-40 (HAMAMATSU, Japan) coupled to a charge-coupled device 
(CCD) camera (HAMAMATSU C9300, 4000×2672 pixels) with an effective pixel 
size of approximately 4 µm. The measured resolution of this configuration of the DEI 
system exceeds 18 µm (20% contrast using a 28 line pair per mm resolution test 
phantom). The x-ray photon energy was set at 20 KeV. 
 
Figure 6.2. Synchrotron radiation  based (SR) diffraction enhanced imaging (DEI) 
setup.37 
 
  For each sample, three projection images were acquired: one at the peak of the 
rocking curve and one on each side of the rocking curve at the half maximum point. 
The image captured at the low angle side of the analyzer crystal is referred to as the 
low angle image (L), and the image captured at the high angle side of the analyzer 
crystal is referred to as the high angle image (H). At each position, three images (a 
sample image, a flat image, and a dark image) were captured for image normalization. 
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All DEI images obtained were then processed using MATLAB 7.7 software 
(Mathworks, Inc.) to form the refraction angle images using the following equation 
(6.1) [204]. 
                     (6.1) 
  where △θZ is the refraction contrast in the plane of diffraction; θH and θL are 
symmetrical angles on both sides of the rocking curve; IH and IL are the intensities in 
the analyzer at θH and θL, respectively; R(θ) is the rocking curve of the analyzer; and 
(dR/dθ)(θH) and (dR/dθ)(θL) are the slopes of the rocking curves at θH and θL, 
respectively. For images obtained at the 50% reflectivity points, R(θL)=R(θH) and 
dR/dθ (θH)=-dR/dθ (θL). 
 
6.2.5 Histology and SEM 
  For histological assessment, scaffolds were embedded in 15×10 mm slices of rat 
muscle tissue that were postfixed using 4% paraformaldehyde in 0.1M PBS overnight 
and then cryoprotected overnight in 20% sucrose at 4 °C. The muscle tissues were 
flash frozen using an acetone and dry ice slurry. The tissues were sectioned on a 
cryostat (Micron, Zeiss, Canada) to 6 µm and stained using a standard Heamotoxylin 
& Eosin protocol (HE). 
  The morphology of the scaffolds was investigated by SEM (EVO60, Zeiss) with an 
accelerator voltage of 20 kV, in which samples were coated with gold using a Denton 
Vacuum Desk IV coater. 
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6.3 Results 
6.3.1 PLLA/chitosan scaffolds 
  The PLLA/chitosan scaffolds were fabricated by using dispensing rapid prototyping 
method. Images of the scaffold were taken by using a camera and SEM are shown in 
Figure 6.3. The SEM image shows morphological features of the scaffold, where the 
rough surface of the strands in the scaffold is due to the presence of chitosan 
microspheres (with a concentration of 66.7%). The scaffold shown in Figure 6.3 (a) 
was used in all x-ray imaging experiments to eliminate potential sample variability 
(e.g., scaffold density) in the comparison of different x-ray imaging techniques. 
 
Figure 6.3. Images of the PLLA/chitosan scaffold from (a) a camera and (b) SEM.38 
 
6.3.2 Imaging the scaffold in air 
  The scaffold in air or A-scaffold was visualized using laboratory-based radiography, 
and SR-radiography, in-line PCI, and DEI techniques (Figure 6.4). The profile of the 
scaffold was visualized using both laboratory-based (Figure 6.4 (a)) and SR- 
radiography (Figure 6.4 (b)) but with poor image details. The principle of these 
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radiography techniques is based on the absorption contrast of imaged objects. As such, 
the low density of the scaffold results in inadequate image contrast. In the DEI 
imaging process, the refraction image (Figure 6.4 (d)), which was obtained from both 
the low and high angle images, shows the profile of the scaffold more clearly than the 
radiographs (Figure 6.4 (a and b)) and the in-line PCI image (Figure 6.4 (c)), 
especially, at the edges of the scaffold strands. The refraction contrast image 
represents the spatial gradient of the refractive index (horizontal in Figure 6.4 (d)), 
enhancing and highlighting edge appearance, contour interfaces of polymers, and 
environments. Furthermore, the refraction image reveals detailed information about 
the chitosan microspheres mixed in the strands of the scaffold, which also caused the 
scatter rejected by the analyzer.  
 
Figure 6.4. Comparison of the PLLA/chitosan scaffold images with laboratory-based 
radiography, synchrotron radiation based (SR-) radiography, in-line PCI, and DEI 
using the same sample at a similar magnification. (a) Laboratory -based radiograph at 
60 Kvp, (b) SR radiograph at 20 KeV, (c) in-line PCI image at 20 KeV, and (d) DEI 
image at 20 KeV. (e), (f), (g), and (h) are the gray values corresponding to the color 
lines shown in images (a), (b), (c), and (d), respectively.39 
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  Figure 6.4 (e), (f), (g), and (h) show the gray value changes at the same location of 
the scaffold in the laboratory- and SR- radiographs, in-line PCI image, and DEI 
refraction image, respectively. The grayscale contrast in the refraction image is a 
factor of two higher than in the radiographs and in-line PCI image. Both radiography 
and in-line PCI are affected by x-ray scatter, while DEI can reject x-ray scatter and 
produce a pure refraction image. Compared to in-line PCI, DEI is able to show 
stronger contrast in images and has a higher sensitivity to object edges. Notably, DEI 
is sensitive to gradients in the projected density along a single direction. This effect 
accounts for the weaker contrast variations from the horizontal strands as compared to 
those from vertical ones in Figure 6.4(d). However, the tissue scaffolds are 3D arrays 
of strands so that no matter the orientation of the scaffold, there will be refraction 
contrast. The scaffold material also has scatter contrast (sometimes called extinction 
contrast). The contrast accounts for the other modalities. This type of contrast is 
isotropic and does not depend on the orientation of the strands. During image 
processing, most analyses for qualitative and quantitative detail, such as scaffold 
porosity, pore size, surface area to volume ratio, and interconnectivity, are based on 
image grayscale contrast. As such, appropriate grayscale contrast makes image 
analysis more accurate.   
 
6.3.3 Imaging the scaffold in muscle tissue 
  After being embedded in the muscle tissue, the sample or M-scaffold was imaged 
using laboratory based radiography, in-line PCI, and DEI, respectively (Figure 6.5). 
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Using conventional laboratory based radiography at 60 Kvp, the scaffold tissue is not 
visible and the profile of the muscle tissue is unclear (Figure 6.5 (a)). The contrast of 
the radiograph is based on x-ray attenuation; however, because the attenuation of 
muscle tissue and the polymer scaffold are close due to their similar densities, 
distinguishing them using radiography techniques is difficult. Using in-line PCI at 20 
KeV, the profile of the muscle tissue can be distinguished and the scaffold is faintly 
visible (Figure 6.5 (b)). However, the DEI image clearly shows the M-scaffold and 
has high contrast (Figure 6.5 (c)). The contrast of DEI images is based on the 
refraction and scattering properties of the object. Furthermore, many spots along the 
scaffold strands can be identified in the DEI image (Figure 6.5 (c)) due to the 
presence of the chitosan microspheres, consistent with the A-scaffold DEI image 
(Figure 6.4 (d)). The chitosan microspheres within the strands cause x-ray refraction 
that is captured by the detector throughout the analyzer. Although the scaffold was 
embedded into muscle tissues, the DEI image of the M-scaffold provides the most 
detailed image information of the A-scaffold DEI image (Figure 6.4 (d)).  
 
Figure 6.5. X-ray images of the PLLA/chitosan scaffold embedded in rat muscle 
tissue (M-scaffold): (a) laboratory based radiograph at 60 Kvp, (b) in-line PCI image 
at 20 KeV, and (c) DEI image at 20 KeV. Arrows in (a), (b), and (c) indicate the 
location of the scaffold in the muscle tissue.40 
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  The DEI images of the M-scaffold provide detailed information on the scaffold 
structure as well as the profile of the muscle tissue. In Figure 6.5 (c), many short lines 
can be observed in the muscle tissue area. To identify these features, a histological 
analysis was conducted on the same muscle tissue after the x-ray imaging was 
conducted and the scaffold was removed. Figure 6.6 (a) shows a typical image of the 
muscle tissue at the same location as the DEI image. The light microscopy image 
shows the muscle tissues are separated into many small pieces by some white edges 
(Figure 6.6 (a) arrow) that have a similar distribution to the short lines in the DEI 
image (Figure 6.5 (c)). By magnifying the edge area in the muscle tissue, the 
histological image (Figure 6.6 (b)) indicates that the connective tissues pack the 
muscle cells into bundles of muscle fibers, with boundary interfaces formed between 
them. The presence of this detail indicates that the DEI technique is sensitive to 
refraction differences inside the soft tissues and is thus able to provide structural 
information about the soft tissues, particularly "edges" inside the tissue microstructure. 
The comparison of the DEI image to the histological analysis suggests that the 
structure discrepancy in soft tissues can be reflected in DEI images.   
 
Figure 6.6. Light microscopy images: (a) a typical stained histological slices of the 
same muscle tissue used to embed the PLLA/chitosan scaffold and (b) magnified light 
microscopy image of the muscle tissue. (The arrow in image (a) points to the typical 
microstructure in the muscle tissue, which is magnified in image (b).)41 
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6.3.4 Effect of sample thickness for DEI 
  To investigate the effect of soft tissue thickness on the visualization of low density 
scaffolds, the PLLA/chitosan scaffold was immersed into water (W-scaffold) and 
imaged using DEI at a photon energy of 20 KeV. Water was used as a substitute for 
soft tissue in this investigation; imaging results for scaffolds in water are  
comparable to scaffolds in soft tissue and water has a similar density and x-ray mass 
attenuation coefficient as soft tissue. The results illustrated that the scaffold is clearly 
distinguishable in the DEI refraction images at sample thicknesses of 1 and 4 cm 
(Figure 6.7 (a) and (b)) but not 5 cm (not shown). Figures 6.7 (c) and (d) show the 
gray value changes at the same location of the scaffold marked in Figure 6.7s (a) and 
(b), respectively. The grayscale contrast in both DEI images is similar, with the 
grayscale contrast of the 4 cm thick W-scaffold not significantly less than the 1 cm 
thick W-scaffold. These results suggest the DEI system at 20 KeV is capable of 
distinguishing the PLLA/chitosan scaffold in soft tissues with thickness up to 
approximately 4 cm. 
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Figure 6.7. DEI images of the PLLA/chitosan scaffold in water (W-scaffold) at a 
photon energy of 20 KeV and total sample thicknesses of (a) 1 cm and (b) 4 cm. (c) 
and (d) are the gray value changes corresponding to the locations marked in images (a) 
and (b), respectively.42 
 
6.3.5 Radiation dose and radiograph quality 
  The surface absorbed dose rates experienced by the scaffolds at different average 
photon energies during x-ray imaging were evaluated according to the following 
equation [302]: 
  )(0 enabsphph AENED 
 
                                             (6.2)
 
  where D (Eph) is the surface absorbed dose rate to the sample; 0N  is the photon 
fluence rate, measured using a gas ionization chamber; Eph is the average photon 
energy; enabs
  is the mass energy absorption coefficient of the sample; and A is the 
sample area. 
 
  As the x-ray photon energies increase, the dose rates of the sample decreased 
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(Table 1); for example, photon energy increase of ~60% (from 15 to 25 KeV) results 
in a dose rate reduced of ~60% (from2.16 to 0.86 mGy/s). 
  The image contrast of the A-scaffold in the SR-radiographs at different photon 
energies is shown in Figure 6.8 (d-f). The images become blurry (Figure 6.8 (a-c)) and 
image contrast substantially declines as the photon energy is increased; for example, 
the scaffold in Figure 6.8 (a) is clearly visible at a photon energy of 15 KeV but is 
barely visible at a photon energy of 25 KeV. The results indicate that better x-ray 
attenuation contrast of samples can be obtained using radiography at lower photon 
energies but the sample is consequently exposed to higher dose rates. 
 
Figure 6.8. SR-radiographs and corresponding image contrast of the A-scaffold at 
different photon energies with the sample to detector distance (SD) of 2 cm: (a) at 15 
KeV, (b) at 20 KeV, and (c) at 25 KeV; (d), (e), and (f) are the gray value changes 
corresponding to the color lines shown in images a, b, and c, respectively. All image 
contrasts were measured at the same location of the scaffold.43 
 
6.4 Discussion 
  The present study illustrates, for the first time, the possibilities of DEI for the 
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visualization of low density tissue scaffolds. Specifically, the PLLA/chitosan scaffold 
was visualized in both air environment and muscle tissue using different x-ray 
imaging techniques including laboratory- and SR- radiography, in-line PCI, and DEI. 
For comparison, all the images were captured from the same scaffold sample. The 
DEI technique can visualize low density scaffolds in muscle tissue better than any of 
the other techniques considered here. Moreover, DEI has the potential to be fully 
non-invasive and non-destructive for both in vitro and in vivo applications in soft 
tissue engineering research. This would allow low density scaffolds to remain intact 
for additional assessments as well as facilitate the monitoring of either degradation 
behaviour or new tissue ingrowth after implantation, which is especially relevant for 
pre-clinical trial applications. Inspired by the promising results from the present study 
and the fact that the integration of DEI and computed tomography techniques (i.e., 
DEI-CT) can provide 3D visualization of tissue samples, such as breast tissue [211], 
the DEI-CT can be applied to realize the 3D visualization of engineered scaffolds and 
newly-generated tissues in vivo.  
  Scatter is a problem in conventional x-ray imaging where it is common for over 
half of the x-rays that reach the detector to be of scatter origin. Thus, anti-scatter grids 
are used to reject some of this scatter which improves image contrast. In DEI 
technique, however, the use of an analyzer can reject off-angle and off-energy 
scattered x-rays primarily from Compton scattering. As such, this technique is almost 
scatter free [204]. This effect of extreme scatter rejection has two key advantages. 
First, this effect can be used to enhance the contrast from small structural features, 
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such as lung alveoli, fur, and etc., from rejection of ultra-small x-ray scattering [212]. 
Second, another important effect is that the increased scatter from thick objects 
becomes almost completely irrelevant, which allows them to be imaged at no loss of 
contrast due to scatter (see Figure 7). This is part of the reason why DEI is so 
successful at imaging large thick objects at higher x-ray energies [303]. In this study, 
the ability to image the PLLA/chitosan scaffold in soft tissue using DEI at 20 KeV 
was limited to sample thicknesses up to approximately 4 cm; the reason is that a 
log-linear relationship between the transmitted photon flux and the sample thickness 
prevented further penetration [304]. Higher x-ray energy DEI systems with higher 
photon fluxes can visualize thicker tissue samples; for example, breast tissue samples 
with thickness of 12 cm have been clearly visualized at 60 KeV [305].  
  Degradation of resolution due to the DEI system was not observed in this work. 
The resolution of the DEI system is determined by source size, the pixel size of the 
detector, and the distances between the source, object, and detector; also, there will be 
a small (approximately 1 µm) contribution in the diffraction plane due to beam 
penetration into the analyzer crystal. The current resolution could meet the 
requirements of the tissue level and scaffold degradation studies in situ and possibly 
in vivo. Considering the potential variety of samples and wide range of sizes relevant 
for soft tissue engineering applications, higher resolution imaging systems might be 
helpful for smaller fields of view while low resolution systems with a large field of 
view may be more useful for in vivo applications.  
  During x-ray imaging, the dose absorbed by the sample is lower at higher photon 
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energy levels. Photoelectric absorption in the sample contributes to the main part of 
the total attenuation at low photon energy levels (and a high dose received by the 
sample), while Compton scatter in the sample plays the leading role in the processes 
at high photon energy levels [306]. In conventional radiography, absorption contrast is 
directly related to the dose received by the sample. Better image contrast means more 
absorbed x-rays and more dose to the sample at lower photon energy levels [212]. In 
tissue engineering applications, high dose x-ray imaging processes will change the 
material properties of the imaged scaffolds and the biological properties of the imaged 
tissues. The harmful effects of ionizing radiation present in conventional x-ray 
imaging are a notable challenge to applying these techniques to tissue engineering, 
especially for in vivo visualization [294]. In DEI, the sample absorbs the same dose as 
conventional radiography at the same x-ray energy, but additional image contrast is 
generated from x-ray refraction. Thus, compared with radiographs at the same energy 
level, DEI images of scaffolds embedded in muscle tissue demonstrate higher contrast. 
Furthermore, DEI can be optimally applied at higher x-ray energies and lower doses 
in visualization applications [204]. When 2D x-ray imaging techniques are extended 
to 3D applications, the combination of DEI and tomography techniques will cause 
order-of-magnitude reductions in radiation dose and offers great promise for the 
visualization and characterization of scaffolds and regenerative tissues in living 
animals. 
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6.5 Conclusions 
  Visualization of low density materials using conventional radiography is a 
challenging task due to weak x-ray attenuation. Rising to this challenge, the low 
density PLLA/chitosan scaffolds were visualized by DEI and compared our results to 
conventional radiography and in-line PCI. When visualized in air, the DEI images of 
the scaffolds were much clearer compared to radiographs and in-line PCI images. DEI 
was also demonstrated to have the capacity to provide enhanced image contrast that 
could reveal detailed morphology of low density scaffolds. After embedding the 
scaffold into rat muscle tissue, the images obtained shows DEI can provide higher 
quality visualization of scaffolds as compared to both radiography and in-line PCI. 
The DEI images not only show the structure of the scaffold but also the 
microstructural features of the muscle tissue. In addition, the DEI technique 
accomplishes good imaging performance with low radiation doses at high energy 
levels. Overall, DEI technique has great potential for visualization applications in soft 
tissue engineering, in particular the real-time observation of engineered tissues in 
living animals. 
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CHAPTER 7 
CONCLUSIONS AND RECOMMENDATIONS 
 
7.1 Conclusions 
  The aim of this research is to develop and characterize 3D biodegradable scaffolds 
for potential peripheral nerve tissue regeneration. The main conclusions of this 
research are summarized as follows: 
  (1) The orientation of axon growth in scaffolds can be achieved in an artificially 
patterned substrate by creating selective high-affinity pathways in scaffolds. The 2D 
micropatterns were designed to impart directionality to the growth of neurites, which 
take advantage of the DBRP technique. In vitro experimental results demonstrated 
DRG neurites on these patterns preferentially grew upon and followed the 
laminin-blended chitosan pathways compared to the pure chitosan pathways. 
  (2) Compared to the DBRP technique, RFP is able to achieve an improved porous 
structure of scaffolds which includes higher porosity, enhanced pore size distribution 
and thinner wall thickness. The improved porous structure would facilitate cell and 
tissue migration and vascularization. 
  (3) The combination of CMs and PLLA can effectively control the release of 
bioactive molecules from the scaffolds and control the mechanical properties of the 
scaffolds. The experimental results of the BSA release demonstrate that the use of the 
CMs is an effective way to administrate the BSA release and that its rate can be 
controlled by adjusting the crosslinking degree of the CMs. Thus the BSA release 
period can be prolonged after the CMs are embedded into the PLLA scaffolds. The 
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experimental results also show that the addition of the CMs to the PLLA scaffolds can 
improve the mechanical properties of the scaffolds which also depend on the 
cryogenic temperature used in the scaffold fabrication process.  
  (4) The biodegradation behavior of PLLA can be regulated and adjusted by adding 
CMs. The results obtained from in vitro degradation experiments of PLLA/CMs 
scaffolds showed that there was a decrease in the degradation rate of the composite 
scaffolds in phosphate-buffer solution with pH 7.4 at 37°C after 8 weeks compared 
with pure PLLA scaffolds. The addition of CMs into PLLA slowed the hydrolysis of 
PLLA after 4 weeks degradation and also resulted in the decrease of PLLA 
crystallinity during scaffold fabrication.  
  (5) The μCT technique employed in scaffold degradation studies is capable of 
monitoring microstructural changes of scaffolds. This new application allows a deeper 
insight towards understanding scaffold degradation behavior and possible 
visualization of new tissue growth as well. 
  (6) The DEI technique has a great potential for in vivo visualization applications in 
nerve tissue engineering. In order to explore the visualization of low density polymer 
scaffolds in vivo, the PLLA/chitosan scaffolds were imaged by DEI and compared to 
the results obtained from conventional radiography and in-line PCI. After embedding 
the scaffold into rat muscle tissue, the images obtained demonstrate DEI can provide 
higher quality images of scaffolds as compared to both radiography and in-line PCI 
which not only show the structure of the scaffolds but also the microstructural features 
of the muscle tissue. In addition, the DEI technique accomplishes good imaging 
performance with low radiation doses at high x-ray imaging energy levels.  
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7.2 Recommendations for future work 
  Based upon the work presented in this dissertation, a number of projects are 
recommended for future research. 
  (1) The 2D micropattern model has been successfully created to guide the 
directional growth of axons in vitro. Based on this 2D design, a 3D PLLA/CMs 
scaffold with bioactive molecules, such as laminin, could be developed by means of 
the DBRP technique for the studies of axon guidance in vitro. Bioactive 
molecule-loaded CMs will only be located in the inner layers of the nerve conduits 
along the longitudinal direction to promote directional axon growth. Additionally, 
using 3D pattern scaffolds, the scaffolds will provide not only biochemical cues but 
also geometric cues for neurite directional growth [111]. 
  (2) One of the future investigations could be aimed to develop the ability of the 
nerve conduit scaffolds so as to manipulate cellular and tissue growth in the presence 
of multiple biochemical cues and more complex structured micro-environments. 
Based on the design of PLLA/CMs scaffolds, the CMs loaded with different 
neurotrophins, such as NGF or BDNF, could be embedded into the PLLA strands 
with a designed ratio of NGF-loaded CMs to BDNF-loaded CMs. The multiple 
neurotrophins encapsulated scaffolds may better support and promote axon 
outgrowth.  
  (3) Neurotrophin gradients in the scaffolds may enable another means to control 
guiding axon outgrowth. A dynamic mixing method may be developed to create 
neurotrophin-loaded strands with concentration gradients by means of DBRP. Briefly, 
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a strategy for gradient generation is to use two dispensers loaded with non- and 
neurotrophin-loaded CMs to pump different solutions at controllable flow rates into a 
mixer and to extrude the mixed solution with designed neurotrophin concentration to 
the substrate. 
  (4) Synchrotron based DEI, as a non-invasive and non-destructive imaging 
technique, has been successfully applied in the visualization of low density polymer 
scaffolds and soft tissues. Coupling with the computed tomography technique, 
DEI-CT can obtain 3D imaging information of the scaffolds and new tissue. During in 
vivo experiments of the nerve conduit scaffolds, 3D images of the in vivo samples 
could be reconstructed based on a series of DEI projection images. DEI-CT can 
provide quantitative results based on different gray levels in reconstructed images of 
the axon outgrowth and scaffold degradation. It also shows a great potential for the 
real-time observation of engineered tissues in living animals due to the low radiation 
dose accumulated during the imaging processes.  
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